Enzymatic Synthesis of Galactooligosaccharides From Whey Permeate by Manucci, Federica
Technological University Dublin 
ARROW@TU Dublin 
Masters Tourism and Food 
2009-07-01 
Enzymatic Synthesis of Galactooligosaccharides From Whey 
Permeate 
Federica Manucci 
Technological University Dublin 
Follow this and additional works at: https://arrow.tudublin.ie/tourmas 
 Part of the Food Science Commons 
Recommended Citation 
Mannucci, F.: Enzymatic Synthesis of Galactooligosaccharides From Whey Permeate. M.Phil Thesis. 
Technological University Dublin, 2009 
This Theses, Masters is brought to you for free and open 
access by the Tourism and Food at ARROW@TU Dublin. It 
has been accepted for inclusion in Masters by an 
authorized administrator of ARROW@TU Dublin. For more 
information, please contact 
yvonne.desmond@tudublin.ie, arrow.admin@tudublin.ie, 
brian.widdis@tudublin.ie. 
This work is licensed under a Creative Commons 
Attribution-Noncommercial-Share Alike 3.0 License 
  
 
 
 
Enzymatic synthesis of Galactooligosaccharides 
from Whey Permeate 
 
 
A thesis submitted to Dublin Institute of Technology in fulfilment of the requirements 
For the degree of MPhil 
 
 
Federica Manucci 
 
Based on research carried out in the  
School of Food Science & Environmental Health, Dublin Institute of Technology 
 
Under the supervision of 
 Prof. Gary T.M. Henehan & Dr. Jesús María Frías Celayeta 
 
 
July 2009 
 ii
ABSTRACT  
 
Galactooligosaccharides (GOS) are prebiotics that have a beneficial effect on human 
health by promoting the growth of probiotic bacteria in the gut. GOS are commonly 
produced from lactose in a reaction catalysed by β-galactosidase, termed 
transglycosylation.  
In the present work the synthesis of GOS from Whey Permeate (WP) using 
commercially available β-galactosidases was studied. The enzymes used were from 
Kluyveromyces lactis (Maxilact® L2000) and Escherichia coli.  
Initially, a novel quantitative TLC-based assay to monitor GOS synthesis was 
developed. This method was employed for kinetic analysis but precision and bias 
problems in quantification were observed. An HPLC assay was subsequently 
developed and used to quantitate the kinetics of GOS synthesis. 
The influence of substrate concentrations of WP and enzyme concentrations were 
examined. The reaction kinetics showed an exponential consumption of lactose, while 
the GOS reached a maximum level and decreased thereafter. The data showed that the 
enzyme and WP concentrations influenced the maximum level of GOS synthesis. The 
maximum yield of GOS from WP was found to be 24%.  
Modelling of GOS synthesis profiles using a full reaction mechanism (Kim et al., 
2004) fitted the experimental data. However, high correlation between kinetic 
parameters and high standard errors in parameter estimates were found. Therefore, a 
simplified GOS synthesis mechanism based on simplifying assumptions previously 
identified in literature was devised. This reduced model fitted data appropriately and 
parameter estimation and associated uncertainty was improved. 
The influence of low amounts of organic solvents on GOS synthesis was examined. 
The progress curve in the presence of solvents was probed using the reduced reaction 
mechanism model.  
To examine the influence of the source of enzyme on GOS synthesis, two β-
galactosidases were compared. Data showed that when reaction conditions were 
identical there was no significant difference in GOS synthesis observed. 
These studies show Whey Permeate is a useful material for GOS synthesis. They 
confirm the literature observations that enzyme and substrate concentrations strongly 
influence GOS yields. The use of organic solvents was found to modify the reaction 
kinetics, with promising applications to increase GOS yield. However, the source of 
enzyme may not influence GOS synthesis to the extent believed in the literature.  
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1 Introduction 
1.1 General 
The dairy industry is one of the oldest and most developed industries in the 
world. In particular, the European dairy industry is transforming 130 billion litres of 
raw milk every year into a broad range of products, both for consumption and for 
application in the production of food, feed and pharmaceutical products (Hilliam, 
1990).    
The dairy industry produces a large quantity of by-products, which requires 
that particular attention is paid to their disposal due to the dissolved sugars, proteins, 
fats, and residues of additives, contained in the effluents. According to the World 
Bank Group (1996), in the untreated effluents of the dairy industry, the biochemical 
oxygen demand (BOD) has an average value ranging from 0.8-2.5 kg/t. The effluent 
chemical oxygen demand (COD) is normally about 1.5 times the BOD level and the 
total suspended solids are about 100 to 1,000 mg/l, of which phosphorus comprises 10 
to 100 mg/l and nitrogen 6% of BOD level. 
The major source of BOD in wastewater of dairy industries derives from the 
production processes for butter, cream, and cheese. The latter gives rise to whey as a 
by-product. Annual global milk production in 2007 is estimated of over 534 
thousands of metric tons, whose transformation to cheese gave up to two thousand of 
metric tons of whey (Commodity Research of Bureau, 2007).  Whey accounts for 
most of the BOD, between 38,000-40,000 ppm (Bullerman et al., 1966), and 
dissolved salts of dairy industries wastewater. Considering the 3% annual increase in 
cheese production (Foda et al., 2000) whey surplus is a major and increasing concern 
for the dairy industry. 
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However, most of the solid waste of the dairy industry can be further utilized 
or processed. A common use for surplus whey is its addition to animal feed, 
especially in America, with 90% of American production used (Wastendorf, 2000). 
Whey has been also been used as a fertilizer, because it improves soil texture and 
contains nutrients, such as nitrogen, phosphorus, and potassium in the proper 
proportions (Yang et al., 1995). Whey needs to be treated before it can be used as 
fertilizer. In the past many industries discharged whey into lakes and rivers to remove 
the economic burden of disposing of whey in waste treatment facilities. In recent 
years, the Environmental Protection Agency (EPA) has placed restrictions on land-
spreading as a method for whey disposal. This serves has served as an important 
incentive to find other uses for whey (Casper et al., 1999). In some European 
countries, such as Italy, France, Greek and Spain, whey almost entirely used for the 
production of a typical soft unreaped cheese, called ricotta, with a production of over 
450 tons (Fox, 1999). 
 
1.1.2 Whey: definition, components and their use 
 Whey is defined as the greenish-yellow coloured liquid obtained after the 
coagulation of casein (Stocking, 2008). It is produced from the process that leads to 
curds formation during the cheese making process (Smithers et al., 1996) (Figure 1.0).  
 
 
 
Figure 1.0: Curds and whey. Milk proteins are precipitated leaving a yellowish 
liquid (whey). 
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Whey contains nearly half of all the solids found in whole milk (Chandan, 
1997). It has about 6.5% solids, of which 4.8% is lactose, 0.6% protein, 0.15% lactic 
acid, 0.25% non-protein nitrogen compounds and 0.1% fat (Ranken et al., 1997).  
Lactose is a disaccharide composed of β-D-Galactopyranosyl and β-D-
Glucopyranose linked with a β-1→4 bond. 
Whey proteins consist predominantly of β-lactoglobulin, α-lactalbumin, 
immunoglobulins and serum albumin. However, whey also contains minerals 
(calcium, magnesium, phosphate, citrate, sodium, potassium and chloride), 
antibacterial peptides (lactoferrin and lactoperoxidase), and vitamins (B1, B2, and C) 
(Wong et al., 1978). 
Depending on how casein is coagulated (acid or enzymatic coagulation), whey 
can be classified as sweet (pH 6.4-6.2) with no calcium, or acid (pH 5.0-4.6), which 
contains a high amount of calcium 92.8 mg/100g (Wong et al., 1978; Yang, 2007). 
Whey, freshly prepared, has a bland flavour (Laye et al., 1993), which allows 
it to blend well with most products. However, it rapidly oxidizes, giving rise to stale 
off-flavours (Morr et al., 1991). For this reason, together with economic aspects of 
transport and storage, whey components are generally separated, through filtration 
techniques such as reverse osmosis or ultrafiltration, and transformed into a dry 
product, through evaporation techniques, such as spray-drying. According to Tamime, 
(2009), Whey powders are manufactured as three main products:  
- Whey protein concentrate (WPC), which contains 70-85% of the whey 
proteins of milk and 50% of the lactose of milk. 
- Whey protein isolate (WPI), which contains more protein (90-98%) 
than WPC and very little fat or lactose. 
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- Whey Permeate (WP), which contains essentially lactose and some 
minerals and minimal fat and protein. 
Whey proteins are commonly used in formulation of infant foods, integrators, 
bakery products, and meat products.  
Currently, whey permeate is mainly used in the manufacturing of dried whey 
powder for the production of refined lactose. The application of whey described 
above, however, are often aimed at keeping the surplus whey out of sewers rather 
producing highly desirable products (Yang, 2007). It is therefore, of interest to 
investigate novel uses of whey permeate.  
 
1.1.3 Oligosaccharides: definition, production, classification  
Oligosaccharides, usually defined as glycosides of different degrees of 
polymerization (DP), may be synthesised both by enzymatic and chemical means. 
Examples of oligosaccharides are: lactulose, raffinose, maltooligosaccharides, inulin, 
fructooligosaccharides (FOS) and galactooligosaccharides (GOS). Lactulose has a 
mildly purgative action and inhibits the growth of ammonia-producing organisms 
(Harju, 1993). Lactulose is currently used as a pharmaceutical for the control of 
constipation and portosystemic encephalophathy (Crittenden et al., 1996). 
Maltooligosaccharides improve colonic conditions by reducing the level of 
Enterobacteriacea in the gut (Nakakuki, 1993). Inulin and FOS are non-cariogenic, 
encourage the growth of beneficial bifidobacteria, and decrease the levels of serum 
cholesterol, phospholipids, and triglycerides (Hidaka et al., 1986). Raffinose ingestion 
increases the number of bifidobacteria (Taizo et al., 1999). 
Chemical synthesis of oligosaccharides can be carried out through the use of 
glycosylating agents, such as glycosyl sulfoxides, glycosyl halides and thioglycosides 
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(Bartolozzi et al., 2001). However, the product mixtures obtained are often quite 
complex and ill defined. Selective synthesis of oligosaccharides requires many 
reaction steps with the use of protection/deprotection of hydroxyl groups, resulting in 
low yields of final products, and often, the formation of unwanted enantiomers 
(Flowers, 1978). 
In contrast to chemical synthesis, enzymatic synthesis of oligosaccharides 
generally produces few by-products, avoids the need for protection/deprotection 
chemistry, and is environmentally of low impact. For these reasons this procedure is 
most commonly used. Thus, transglycosylation of lactose by β-galactosidase is widely 
used to synthesise GOS. Fructanotransferase catalyses the synthesis of FOS from 
sucrose. Lactosucrose can be synthesised from sucrose through the activity of 
levansucrase. Transglycosylation of soluble starch by glycosyl hydrolases is used to 
synthesise glycosylsucrose.  Xylo- and chitin- oligosaccharides may be obtained by 
enzymatic hydrolysis of oligosaccharides using β-xylanase and chitinase respectively. 
Some oligosaccharides, such as inulin and soybean (raffinose and stachyose), can be 
extracted from natural sources (Sako et al., 1999) (Figure 1.1). 
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Figure 1.1: Schematic representation of production processes for non-digestible 
oligosaccharides (NDOs) (from Sako et al., 1999). 
 
Non digestible oligosaccharides (NDOs) are useful as prebiotics. In the 
gastrointestinal tract they serve as substrates for probiotic or “beneficial” bacteria. 
The most common NDOs used as food ingredients are fructooligosaccharides and 
galactooligosaccharides. FOS and GOS are generally produced by enzymatic 
transglycosylation by fructanotransferase and β-galactosidase respectively. The 
industrial process for enzymatic galactooligosaccharides synthesis is shown in Figure 
1.2. 
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Figure 1.2: Industrial production process for GOS. The figure also shows two 
possible types of GOS products: Gal-β-1→4-Gal-β-1→4-Glc (4’-galactosyllactose) 
and Gal-β-1→6-Gal-β-1→4-Glc (6’-galactosyllactose), where Gal: Galactose, Glc: 
Glucose (from Matsumoto et al., 1990). 
 
1.1.3.1 Galactooligosaccharides: definition, functionality and structure 
Galactooligosaccharides have a generic formula of D-Glucose-[β-D-
Galactose]n where n ranges between three and ten sugar moieties. GOS may be 
regarded as non digestible oligosaccharides or soluble dietary fibres because they are 
not digestible by the enzymes of the small intestine, but they are fermentable by 
bacteria in the large intestine (Champ et al., 2003). This is due to the substrate 
specificity of human gastrointestinal digestive enzymes, which are mostly specific for 
α-glycosidic bonds whereas GOS glycosidic bonds have a β-configuration. Some β-
galactosidases, localized in the small intestine, are able to digest GOS but their 
activity is usually weak or often deficient (Ito et al., 1993).  
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Oral GOS assumption beneficially affects the human body by selectively 
stimulating the growth and/or activity of one or a limited number of bacteria in the 
colon. In this way galactooligosaccharides cause a selective modification of the 
intestinal microflora, associated with a decrease in faecal pH (Hidaka et al., 1988). 
Such bacteria are able to create an acid medium unfavourable to the growth of many 
pathogenic microorganisms (Kunz et al., 1993). The end products of fermentation of 
oligosaccharides by colonic bacteria are short chain fatty acids (SCFA) such as acetic, 
propionic and lactic acid (Hidaka et al., 1986; Hidaka et al., 1988), which are thought 
to be efficiently absorbed and utilized by human colonic epithelial cells. In particular, 
acetic and lactic acids are able to inhibit the growth of undesirable bacteria such as 
Esherichia coli and Clostridium perfingens (Tanaka et al., 1983).  
The carbohydrate composition of food is thought to be an important 
determinant of the composition of the intestinal flora (Sako et al., 1999). The 
introduction of GOS into foods is considered desirable (Matsumoto et al., 1989; 
Huffman et al., 1985; Chen et al., 1991).  
A large number of GOS species may be synthesized using an enzymatic 
transglycosylation reaction with lactose as substrate (Tanaka et al., 1983; Smart, 
1993).  
Investigations of GOS synthesis using Aspergillus oryzae (Toba et al., 1978) 
and Streptococcus thermophilus (Matsumoto, 1990) β-galactosidases have identified 
disaccharides containing galactose linked to glucose with various types of glycosidic 
bonds, such as β-1→2, β-1→3, β-1→4, and to galactose through bonds β-1→6 and β-
1→3. Glycosidic bonds between two galactose units are mainly β-1→4 bonds when 
β-galactosidases derived from Bacillus circulans (Mozaffar et al., 1984) and 
Cryptococcus laurentii (Ozawa et al., 1989) are used. The disaccharides synthesized 
_____________________________________________________Chapter 1: Introduction 
 9
by β-galactosidase are also called transgalactosylated disaccharides (TD), since the 
bonds between the monosaccharide moieties are different from those present in 
nature. TDs may be considered as non digestible oligosaccharides (NDOs), since they 
have similar physiological characteristics to GOS. Transgalactosylated disaccharides, 
together with lactose, serve as acceptors for the synthesis of tri- and higher- 
saccharides. It would seem that galactose can be transferred to any of the hydroxyl 
groups on acceptor sugars, except for the C1 hydroxyl (Mahoney, 1998).  
The length of the chain of galactooligosaccharides generated by enzymatic 
reaction depends on the lactose concentration in the media (Huh, 1990; Lopez-Leiva 
et al., 1995; Rustom et al., 1998). Quantitatively, the amount of the different GOS 
products present appears to follow the order: di- > tri- > tetra- > higher- saccharides 
and the linkages synthesized are predominantly β-(1→6) > β-(1→3) and β-(1→2) 
(Prenosil et al., 1987; Toba et al., 1978; Smart, 1993). Trisaccharides, especially 
galactosyl 1→6 lactose, can be identified at most lactose levels. Tetra- and higher- 
saccharides have been reported only when using much higher starting lactose levels, 
although they are considered to be formed at most lactose concentrations but in 
quantities too small to be detected (Mahoney, 1998). Commercially, short chain 
oligosaccharides are preferable to long-chain oligosaccharides as human food 
additives because they are more easily metabolized by the human gut bifidobacteria 
(Mul, 1997) and also because short-chain oligosaccharides, after metabolism in the 
human body, are more efficient in the production of short-chain fatty acids (SCFA) 
(Mul, 1997; Knudsen, 1997).  
A list of oligosaccharide structures identified in GOS preparations is given in 
Table 1.0. 
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Table 1.0: List of oligosaccharide structures identified in GOS preparations. Where 
Gal: Galactose, Glc: Glucose. (Adapted from Mahoney et al., 1998). 
 
 
1.1.4 β-galactosidase: reaction mechanism, products, applications 
β-galactosidase (β-gal) (EC 3.2.1.23) is a galactosyl hydrolase which cleaves 
lactose, releasing glucose and galactose. This enzyme was one of the first enzymes 
isolated and purified from various natural sources, such as plants, animal organs and 
microorganisms (Richmond et al., 1981) (Table 1.1). 
 
Table 1.1: Sources of β-galactosidase (Adapted from Richmond et al., 1981). 
Plants Animal organs Yeast Bacteria Fungi 
Peach 
Apricot 
Almond 
Kefir grains 
Tips of wild roses 
Alfalfa seeds 
Coffee beans 
Intestine 
Brain  
Skin tissue 
Bovine liver 
Kluyveromyces lactis 
Kluyveromyces fragilis  
Candida pseudotropicalis 
Escherichia coli 
Bacillus megaterium 
Thermus acquaticus 
Streptococcus lactis 
S. thermophilus 
L.. bulgaricus 
L. helareticus 
 
Neurospora  crassa 
Aspergillus foetidus 
Aspergillus niger 
Aspergillus flavus 
Aspergillus oryzae 
A. phoenicis 
Mucor pucillus 
Mucor meuhei 
 
The functional form of E. coli β-galactosidase is a tetramer of four identical 
subunits (Appel et al., 1965), each consisting of 1,023 amino acid residues (Fowler et 
al., 1970). The tetramer, of 465.412 Da, has a 222-point of symmetry (Jacobson et al., 
GOS component Chemical structure 
β-D-Gal (1→6)-D-Glc 
β-D-Gal (1→6)-D-Gal 
β-D-Gal (1→3)-D-Glc 
β-D-Gal (1→2)-D-Glc 
Disaccharides 
β-D-Gal (1→3)-D-Gal 
β-D-Gal (1→6)-β-D-Gal (1→6)-D-Glc  
β-D-Gal (1→6)-β-D-Gal (1→4)-D-Glc 
β-D-Gal (1→6)-β-D-Gal (1→6)-D-Gal 
β-D-Gal (1→3)-β-D-Gal (1→4)-D-Glc 
Trisaccharides 
β-D-Gal (1→4)-β-D-Gal (1→4)-D-Glc 
β-D-Gal (1→6)-β-D-Gal (1→6)-β-D-Gal (1→4)-D-Glc 
β-D-Gal (1→6)-β-D-Gal (1→3)-β-D-Gal (1→4)-D-Glc 
Tetrasaccharides 
β-D-Gal (1→3)-β-D-Gal (1→6)-β-D-Gal (1→4)-D-Glc 
Pentasaccharides β-D-Gal (1→6)-β-D-Gal (1→6)-β-D-Gal (1→6)-β-D-Gal(1→4)-D-Glc 
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1994) and consists of five domains, the third of which has the active site (Matthews et 
al., 2005) (Figure 1.3).  
 
 
 
Figure 1.3: 3-D structure of the tetrameric E coli β-galactosidase. The colours 
indicate the four different E. coli identical subunits (From Miesfeld, 2001).  
 
β-galactosidase catalyses the transfer of a galactose moiety of a β-galactoside 
to an acceptor containing a hydroxyl group.  
The reaction mechanism for β-galactosidase has been elucidated and proceeds 
by two steps (Figure 1.4): 
- Step (a): enzyme–galactosyl complex formation and simultaneous 
glucose liberation.  
- Step (b): the enzyme–galactosyl complex is transferred to 
nucleophilic acceptor containing a hydroxyl group. Transfer to water 
produces galactose (hydrolysis reaction, Figure 1.4 b, where -R is a 
hydrogen). Transfer to another sugar produces di-, tri- and higher 
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galactosyl-saccharides, collectively termed galactooligosaccharides 
(Figure 1.4 b, where -R is a sugar molecule). 
 
 
 
 
 
 
 
 
 
Figure 1.4: Reaction mechanism for the hydrolysis and transglycosylation of 
lactose by Kluyveromyces lactis β-galactosidase. (a): The lactose molecule on the 
active site of the enzyme forms and acyl-enzyme complex with liberation of glucose. 
(b): The enzyme-galactose complex, formed by lactose hydrolysis, could react with 
carbohydrate molecules (where R: mono- or di- saccharides), leading to GOS 
formation. Glutamate 551 act as the nucleophile and glutamate 482 is the proton 
donor. (Adapted from Zhou et al., 2001). 
 
In 1957, Roberts et al. showed that transglycosylation by β-galactosidase from 
Saccharomyces fragilis was useful for the synthesis of GOS from lactose. Thus, a 
reaction mixture of 15% of lactose with 0.5% Saccharomyces fragilis β-galactosidase 
leads to formation of GOS from lactose as follows (Figure1.5). 
  
(a) 
(b) 
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Figure 1.5: GOS synthesis from lactose by Saccharomyces fragilis β-
galactosidase. Reactions were carried out in phosphate buffer (0.067M, pH 6.2) and 
35ºC (Roberts et al., 1957). 
 
Therefore, in aqueous solutions with high concentrations of competing 
hydroxyl groups on sugar moieties, the enzyme catalyses the formation of 
galactooligosaccharides (GOS) (Huh, 1990; Lopez-Leiva et al., 1995; Rustom et al., 
1998). The ratio of products results from competition between water and the 
carbohydrate acceptor for enzyme bound substrate (Figure 1.6). 
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Figure 1.6: Reaction pathway for transglycosylation and hydrolysis β-
galactosidase. Lactose hydrolysis (lower path) and transgalactosylation reaction 
(upper path) are both catalysed by β-galactosidase, depending on the sugar 
concentration in solution (Neri, 2008). 
 
Therefore, the β-galactosidase reaction mechanism includes both the 
hydrolysis of lactose and a transglycosylation reaction (Mahoney, 1998). Depending 
on lactose concentration, the reaction is shifted towards either hydrolysis or 
transglycosylation. When water concentration in the system, expressed as water 
activity (aw), is high, the hydrolysis of lactose occurs predominantly. The 
transglycosylation reaction increases with a decrease in water activity (Goulas et al., 
2007).  Apart from lactose concentration, other factors influence the reaction, such as: 
reaction conditions temperature, pH and the presence of inhibitors or activators 
specific for the enzyme (Zárate et al., 1990). 
The β-galactosidase reaction mechanism involves two critical amino acid 
residues on the protein, a proton donor and a nucleophile/base. The mechanism of the 
reaction, first described by Wallenfels et al., (1960), proposed that cysteine and 
histidine residues acted as proton donor and nucleophile site respectively. This was 
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subsequently confirmed (Nizizawa et al., 1970; Nijipels et al., 1981; Prenosil et al., 
1987). However, recent studies (Huh, 1990; Sheu et al., 1998; Mahoney et al., 1998; 
Zhou et al., 2001) have show that microbial β-galactosidases have two glutamate 
residues, one acting as the proton donor and the other as a nucleophile/base (Figure 
1.4). 
Jobe et al. (1972) showed that allolactose, β-D-Galactopyranosyl (1→6)-D-
Glucose, is a primary transfer product of the transglycosylation reaction. They 
demonstrated the capacity of β-galactosidase to modify the 1→4 linkage to a 1→6 
linkage (Figure 1.7). The major pathway for production of this compound is direct 
internal transfer of galactose from the 4 position to the 6 position of the glucose 
moiety without releasing the glucose from the active site (Huber et al., 1976).  
 
 
 
Figure 1.7: Allolactose production from lactose by β-galactosidase. The glycosidic 
linkage 1→4 is modified to 1→6 linkage (from Horton et al., 2006). 
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Many authors (Bakken et al., 1992; Portaccio et al., 1998; Shukla et al., 1993) 
have reported galactose to be a competitive inhibitor of lactose hydrolysis and 
transglycosylation reactions. From a thermodynamic point of view, high galactose 
concentrations might be expected to favour the transglycosylation reaction, increasing 
GOS yield. Nevertheless, Neri et al., (2009) investigating the effects of galactose 
and/or glucose addition on transglycosylation, found a simultaneous decrease in 
lactose hydrolysis and transglycosylation in the presence of galactose, presumably due 
to galactose inhibition (Prenosil et al, 1987; Santos et al., 1998).  
Glucose also influences the transglycosylation reaction kinetics acting as a 
non-competitive inhibitor (Shin et al., 1998; Cavaille et al., 1995).  
According to Peinsipp et al., (1995), during the transglycosylation reaction, 
lactose may serve as donor as well an acceptor of a glycosyl group and the isolated 
product is β-D-Galactose (1→6)-β-D-Galactose-(1→4)-D-Glucose (Figure 1.8).  
 
 
             2 ·Lactose                                    β-D-Gal-(1→6)-β-D-Gal-(1→4)-D-Glc 
 
Figure 1.8: β-D-Galactose-(1→6)-β-D-Galactose-(1→4)-D-Glucose synthesis 
using β-galactosidase.  Lactose is hydrolysed to liberate glucose. The resulting 
enzyme-galactosyl complex reacts to form a 1→6 linkage with the galactose moiety 
of a second lactose molecule (Peinsipp et al., 1995). 
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The efficiency of transglycosylation, the linkage between the units, the 
components in the final product and the yield of GOS have been reported to depend 
upon the source of the enzyme and the reaction conditions used (Sako et al., 1999; 
Boon et al., 2000). Indeed, the degree of oligosaccharide formation has been reported 
to be as high as 40% of the total sugar content of the solution under optimal reaction 
conditions (Prenosil et al., 1987). However, a difficulty with comparison between 
studies lies in the fact that they have been carried out using different enzymes under 
widely varying conditions of temperature and pH and substrate concentration without 
the use of a comparator. 
Transglycosylation is an intermediate step of a more complex reaction 
because, as it progresses, all sugars may be hydrolyzed to their constitutive 
monosaccharides (Matella et al., 2006). Hence, knowledge of the time course of the 
reaction is required to estimate the point of maximum yield for the desired GOS 
products. 
The process of lactose hydrolysis by β-galactosidase is used industrially 
whether the interest in removing lactose from milk products is based on nutritional 
considerations (lactose intolerance) or technological concerns (lactose solubility, 
sweetness, functionality). Lactose-hydrolyzed milk is used for the preparation of 
flavoured milk and fermented products (yoghurt, cheese and bakery products) as it 
accelerates acidification due to the release of glucose. It is also used for ice-creams, as 
it prevents lactose crystallization; as well as a sugar source in animal feed (Yang et 
al., 1995).  
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1.2 Functional food 
The concept of “functional food” was developed in Japan in the mid 1980s. At 
that time, the health authorities in Japan decided that greater consumption of certain 
food types could help to limit or reduce the impact of a number of disease risk factors. 
After a relatively slow start, the concept of functional foods has stimulated 
interest among the major food companies around the world. The functional food 
market is estimated to be worth $43 billion in the US, with an annual market growth 
rate of 5-10% (Sloan, 1999). A European survey estimated the functional food market 
to be worth over about 1€ billion in 1997 (Table 1.2). The global functional food 
market increased from 10,000 US $ million in 1995 (Byrne et al., 1997) to 33,000 $ 
million in the year 2000 (Hilliam, 2000) and is predicted to be over 50,000 in 2010 
(Heller, 2001). Dairy products are one of the most developed sector of the European 
functional food market. 
 
Table 1.2: Functional dairy products in Europe by country (from Hilliam, 2000). 
Country Value in 1999  
(US $ millions) 
Share 
(%) 
Germany 283 21 
France 240 18 
United Kingdom 222 16 
The Netherlands 150 11 
Other countries 450 34 
Total 1345 100 
 
 
1.2.1 Definition of functional foods 
In 1996, Roberfroid was one of the first to define a functional food as “a 
dietary component that may exert physiological effects on the consumer which may 
eventually lead towards justifiable health claims”. While a globally accepted 
definition has yet to be agreed, a functional food is broadly regarded as any food or 
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ingredient that, in addition to providing nutritional benefit, may contribute a health 
benefit (Marriott, 2000). Those benefits can be of various types.  According to 
Bellisle et al., 1998, a functional food affects one or a limited number of functions in 
the body in a targeted way so as to have positive effects on health. Other workers have 
defined such foods as having a physiological or psychological benefit (Clydesdale, 
1997) and/or reducing the risk of chronic disease beyond their basic nutritional 
functions (Hasler, 1998).  
For the food industry, functional properties are those attributes of food 
components or additives that, at their proper concentration and under suitable 
conditions, provide desirable sensory and rheological characteristics (Sikorski, 2001). 
Traditionally, fruits and vegetable have been seen as a source of functional 
food components, but recent investigations have established that animal food 
derivatives, such as milk and dairy products may also be a valuable source of these 
components (Bauman et al., 2006). 
 
1.2.2 Concepts and legislation for functional foods 
The attribution of health claims to foods led to the development of a wide 
variety of foods claiming such benefits. On the one hand, this indicates the extent of 
innovation and competitiveness of the food industry, but on the other hand it 
highlights the need for regulation to ensure legitimacy and that consumers are not 
misled.  
In Europe, the European Commission’s concerted action on Functional Food 
Science in Europe (FUFOSE), involving a large number of the most prominent 
European experts in nutrition and related sciences, were engaged by the International 
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Life Science Institute (ILSI) (Diplock et al., 1999) to define the claims criteria for 
functional foods. 
European Regulation EC No. 1924/2006 harmonises laws, regulations or 
administrative actions in Member States which relate to nutrition and health claims of 
foods in order to ensure the effective functioning of the market whilst providing a 
high level of consumer protection (Official Journal of the European Union, 2007).  
In the European Union (EU) the legal status of functional food is regulated 
through existing food legislation. However, specific authorisation must be obtained 
through the process set out in the Novel Food Regulations prior to placing a new food 
on the EU market (EC No. 258/1997). For these reasons in the EU functional foods 
are not legally considered as a specific food category, but rather a concept (Coppens 
et al., 2006; Stanton et al., 2005).  
In the EU some of the functional foods already available are those with 
cholesterol lowering plant sterols and stanols, as well as those containing live bacteria 
(probiotics) that enhance the quality of human gut microflora. During the manufacture 
of functional fermented milks, oligosaccharides are produced in variable amounts 
depending on the bacterial strains used (Joung et al., 2001; Lamoureux et al., 2002; 
Yadav et al., 2007), so the functional properties of fermented milks may be due not 
only to their probiotic properties but also to the presence of oligosaccharides 
(Martínez-Villaluenga et al., 2008). 
Functional food research has moved progressively towards the development of 
dietary supplementation, introducing the concept of prebiotics, which may affect gut 
microbial composition (Ziemer et al., 1998). 
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1.3 Oligosaccharides industrial properties or applications and prebiotics 
properties 
In 1991, the Ministry of Health and Welfare in Japan legislated as foods for 
specified health use (FOSHU): fructo, galacto, xylo-, isomalto- soybean, lactosucrose, 
raffinose, lactulose and palatinose oligosaccharides (Farnworth, 1997; Sako et al., 
1999).  
Oligosaccharides are water soluble and have a relatively low sweetness (about 
0.3-0.6 time that of sucrose), which depends on their chemical structure and molecular 
mass. For this reason they are used as bulking agents and as carriers for other food 
flavours, natural or artificial. Because of their high molecular weight, 
oligosaccharides provide increased viscosity, leading to improved body and 
mounthfeel (Crittenden et al., 1996; Tamine, 2005). Other applications include the 
alteration of the freezing temperature of frozen foods, and the control of the amount of 
browning in heat-processed foods. Oligosaccharides have also been shown to be 
strong inhibitors of starch retrogradation. 
As soluble dietary fibre, oligosaccharides are commonly used as low-
cariogenic sugar substitutes in confectionery, jams, pastry, chewing gums, yoghurts, 
drinks, and in low calorie diet and diabetic foods (Matsumoto et al., 1995). 
Studies regarding the in vitro cariogenicity of trans-galactooligosaccharides 
(TOS) (Hartemink et al., 1997) proved that many oral bacteria are able to degrade and 
ferment TOS and galactosyl-lactose (GLL). Although lactic and acetic acid are 
produced, the fermentation process is relatively slow. Plaque is not formed, so the risk 
of caries formation from TOS and GLL is considered rather low.  
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 The caloric value of non digestible oligosaccharides has been estimated to be 
1.0-2.0 kcal/g (Roberfroid et al., 1993). In particular, Watanuki et al. (1996) 
calculated the caloric value of GOS as 1.73 kcal/g.  
GOS are stable compounds, and they remain unchanged even after high 
temperature treatment and are also quite stable during long-term storage at room 
temperature. It has been suggested that their stability is better than 
fructooligosaccharides (Voragen, 1998). This property allows their use in thermally 
treated foods. 
Oligosaccharides are referred as bifidogenic or bifidofactors, referring to their 
ability to selectively promote the proliferation of: Bifidobacteria spp. (such as B. 
longum, B. breve, B. pseudolongum, B. infantis and B. lactis) and Lactobacillus spp. 
(such as L. acidophilus, L. casei, L. reuteri, L. rhamnosus, L. johnsonii, and L. 
plantarum) which are believed to be beneficial to intestinal health (Shortt, 1999). 
Such bacteria have been described as friendly bacteria or probiotic (from the Greek, 
πρo βιοτος, meaning literally ‘for life’). The incorporation of probiotic strains in 
traditional food products has been well established in the dairy industry, leading to the 
production of novel types of fermented milks and cheeses (Gomes et al, 1999). 
Gibson and Roberfroid (1995), defined a prebiotic as a non-digestible food 
ingredient which beneficially affects the host by selectively stimulating the growth 
and/or metabolism of one or a limited number of beneficial bacterial species already 
existent in the colon. Thus, a prebiotic not hydrolyzed and/or absorbed in the upper 
part of the gastrointestinal tract, serves as a selective substrate for at least one 
beneficial colon bacterial species in such a way as to alter positively the composition 
of the microflora.  
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Many food ingredients such as non-digestible oligosaccharides, some peptides 
and proteins and certain lipids, could act as prebiotics but only the oligosaccharides 
are able to fulfil all the criteria of prebiotics as defined above. Oligosaccharides and 
specifically, galactooligosaccharides achieve this by acting as a selective carbon and 
energy source that “friendly” bacteria can utilize. Organisms such as Escherichia coli, 
Clostridium perfringens or Streptococcus mutans, potentially harmful residents of the 
gut, cannot utilize GOS (Tomomatsu, 1994). This leads to an improvement of the 
balance of intestinal microflora in the gut.  
Another strategy in microflora management is the use of synbiotics, in which 
prebiotics and probiotics are used in combination (Gibson et al., 1995). The live 
microbial additions may be used in conjunction with specific substrate for growth (i.e. 
Bifidobacteria with GOS or FOS) (Collins et al., 1999). 
There are studies and advances occurring in the medical applications of 
specific oligosaccharides. For example, the treatment of gut infectious diseases using 
oligosaccharides has been proposed by Playne (2002), who discovered the ability of 
specific oligosaccharides to bind to gut mucosal and epithelial surfaces and thus 
prevent the attachment of certain microorganisms.  
Other investigations established that the presence of Bifidus microflora in the 
intestines of breast-fed infants was attributed to the presence of GOS in human milk 
(Matsumoto, 1993). Gyorgy (1973) showed that the galactooligosaccharides fraction 
of human milk (referred as Bifidus factor) enhanced the growth of Bifidobacteria in 
the intestine not only of breast-fed infants but also of infants fed with cow's milk 
supplemented with GOS. 
Galactooligosaccharides have other potential beneficial effects in addition to 
being bifidofactors. Thus they have been reported to:  
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- Help synthesis of B-complex vitamins (B1, B2, B3, B6, B9, B12), produced 
by Bifidobacteria strains (Perugino et al., 2004; Kanbe, 1992).  
- Reduce serum cholesterol levels due to assimilation of cholesterol in the 
diet by some strains of Lactobacillus acidophillus (Chonan et al., 1995, 
Gilliland et al., 1990). 
-  Stimulate and enhance mineral absorption of metals such as calcium and 
magnesium (Sako et al., 1999). In particular, calcium solubility increases 
as a result of SCFA production by Bifidobacteria (Chonan et al., 1995). 
- Affect positively bone mineralization (Chonan et al., 1995; Scholz-Arhens 
et al., 2001). 
- Improve blood glucose and triglycerides level (Nakakuki, 2002). 
- Eliminate toxic compounds (Van den Heuvel et al., 1999), such as 
ammonia (Tamai et al., 1992). 
- Stimulate intestinal peristalsis as a result of SFCA production thereby, 
preventing constipation (Deguchi, 1997).  
- Have anticariogenic activity (Delzenne, 1999). 
- To relieve the symptoms of diabetes mellitus and lactose intolerance (Li et 
al, 2008). 
- Prevent colon cancer (Van Dokkum et al., 1999). 
GOS are generally recognized as safe (GRAS) as they are components of 
human milk and traditional yoghurt products. Acute and chronic toxicity tests showed 
no toxicity as well as no mutagenicity for GOS (Sako et al., 1999). 
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1.3.1 Galactooligosaccharides dose-response in prebiotic effect  
The prebiotic properties of several oligosaccharides have been demonstrated 
by the administration of reduced amounts of the products to animals (Kikuchi et al., 
1993; Korpela et al., 1997; Mul, 1997). Caecal enlargement and increases in caecal 
contents are common in animals after consumption of GOS. Bouhnik et al. (1997) 
compared the in vitro activity of a batch human faecal culture in relation to the 
production of adenosine-5-triphosphate (ATP), acid and gas of healthy humans. The 
analysis of faeces collected on day 1 (control), 7 days and 14 days after the 
administration of GOS found that, in response to added GOS, ATP and acid 
production were stimulated. In addition, the rate of increase of acetic acid in the batch 
culture in the presence of GOS was higher than that of the control group. This study 
suggested that the increase in ATP and acid production was due to the change in 
composition of the faecal flora to a bifidobacteria-predominant one.  
A human study with galactooligosaccharides and fructooligosaccharides as 
prebiotics showed that a daily dose of 4-20 g significantly increases Lactobacilli and 
Bifidobacteria levels in the gut (Ryocroft et al., 1999). Similarly, earlier studies by 
Tanaka et al. (1983) demonstrated that after a week of intake of β-1→6 GOS at a dose 
of 3-10 g/day in healthy adults, the faecal count of bifidobacteria increased in a dose-
dependent manner. Indeed, a daily intake of 2.5 g of β-1→6 GOS appears to be 
sufficient to increase the faecal Bifidobacteria count when the initial baseline level is 
low, which is often the case in elderly people (Ito et al., 1993). Boehm et al., (2000) 
performed studies in preterm infants where they tested the probiotic capacity of an 
oligosaccharide mixture consisting of 90% of galactooligosaccharides and 10% 
fructooligosaccharides. A mixture of 1 g/dl of GOS and FOS, similar to the 
oligosaccharide content of human milk, cannot stimulate intestinal Bifidobacteria in 
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formula-fed infants. However, the number of Bifidobacteria found in the infants fed 
with the oligosaccharide mixture was in the upper range of the values found in infants 
fed with human milk. Further studies, Moro et al. (2002), demonstrated that a 
concentration of 0.4 g/dl of the galacto and fructo oligosaccharide mixture is 
bifidogenic and that doubling the amount of oligosaccharides in the feed increased the 
effect. Kanamori et al., (2003) also showed that oral administration of a synbiotic 
containing GOS (3 g/day) in combination with vancomycin helped to eradicate 
methicillin-resistant Staphilococcus aureus (MRSA) and re-established an anaerobic-
dominant flora in a 3 month old infant suffering from MRSA entercolitis. Deguchi et 
al., (1997) showed that bowel habit is improved after daily ingestion of 5 g GOS for a 
week. In a study of diabetic subjects with constipation, a correlation was found 
between the improvement in constipation and the decrease in faecal Bacteriodaceae 
after ingestion of GOS (Narimaya et al., 1996). 
 
1.4 Galactooligosaccharides industrial production 
Oligosaccharides and their derivatives play a key role in many biochemical 
reactions and their use in therapeutics, as diagnostic tools, in cosmetics and the food 
industry is well established (Monsan et al., 1995). The estimated production of non 
digestible oligosaccharides in the world grew since the inclusion of GOS in FOSHU: 
over 300 products have been approved (Arai et al., 2002), more then half of which 
(except for lactulose) are consumed in Japan, with a market value of approximately 10 
billion yen (Sako et al., 1999). Furthermore, 60% of FOSHU items so far are products 
containing non digestible oligosaccharides. Examples of specific products containing 
galactooligosaccharides recently approved are outlined in Table 1.3 (Tamine, 2005). 
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Table 1.3: Recent FOSHU introduction containing oligosaccharides (Adapted from 
Tamine, 2005). 
Claim area Company name Product detail 
Como Croissants with lactosucrose 
UCC Ueshima Coffee Powdered soft drink with lactosucrose 
Nihon Seibutsu Kakagu Table top GOS 
Nissin Sugar Manufacturing Table top GOS 
Intestinal 
health 
Yakult Honsha Soft drink with GOS and polydextrose yogurt with prebiotics 
(Lactobacillus gasseri and Bifidobacterium bifidum) 
 
Estimated GOS production in 1995 in Europe was about 15,000 tonnes 
(Playne et al., 1996). Examples of companies that are currently involved in GOS 
production are Friesland Foods Domo in The Netherlands or Snow Brand Milk 
Products in Japan.  
Vivinal® GOS (from Friesland Foods) or P7L® GOS (Snow Brand Milk), 
whose production process are patented, are used to formulate products targeting 
specific groups such as infants, children, women and the elderly. Commercially 
available GOS is a mixture of several species of GOS. The typical composition of 
Vivinal is GOS (more than ~55%), lactose (~20%), glucose (~20%) and a small 
amount of galactose (less than 1%).  
Worldwide, there are 12 classes of food grade oligosaccharides in commercial 
production and the production in 1995 (latest data available with details from 
manufacturers) can be seen in Table 1.4. 
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Table 1.4: Yields of produced food-grade oligosaccharides in 1995 by manufacturer 
(Adapted from Crittenden et al., 1996) 
Class of oligosaccharides Estimated 
production 
in 1995 (t) 
Major manufacturers Trade names 
Yakult Honsha (Japan) Oligomate 
Nissin Sugar Manufacturing Company (Japan) Cup-Oligo 
Snow Brand Milk Products (Japan) P7L and others 
GOS 15000 
Borculo Whey Products (The Netherlands) TOS-Syrup 
Morinaga Milk Industry Co. (Japan) MLS/P/C 
Solvay (Germany) 
Milei GmbH (Germany) 
Canlac Corporation (Canada) 
Laevosun (Austria) 
Lactulose 20000 
lnalco SPA (Italy) 
 
Ensuiko Sugar Refining Co. (Japan) Newka-Oligo Lactosucrose 1600 
Hayashibara Shoji Inc. (Japan) Newka-Oligo 
Meiji Seika Kaisha (Japan) Meioligo 
Beghin-Meiji Industries (France) Actilight 
Golden Technologies (USA) NutraFlora 
Cheil Foods and Chemicals (Korea) Oligo-Sugar 
ORAFTI (Belgium) Rafilose and Raftiline 
FOS  12000 
Cosucra (Belgium) Fibruline 
Isomaltulose oligosaccharides 5000 Mitsui Sugar Co. (Japan) ICP/O 
Glucosyl sucrose 4000 Hayashibara Shoji Inc. (Japan) Coupling Sugar 
Nihon Shokuhin Kako (Japan) Fuji-Oligo Maltooligosaccharides 10000 
Hayashibara Shoji Inc. (Japan) Tetrup 
Showa Sangyo (Japan) lsomalto-900 
Hayashibara Shoji Inc. (Japan) Panorup 
Isomaltooligosaccharides 11000 
Nihon Shokuhin Kako (Japan) Biotose and Panorich 
Nihon Shokuhin Kako (Japan) Celdex 
Ensuiko Sugar Refining Co. (Japan) Dexy Pearl 
Cyclodextrine 4000 
Asahi Kasei Kagyo Co. (Japan)  
Gentiooligosaccharides 400 Nihon Shokuhin Kako (Japan) Gentiose 
Soybean oligosaccharides 
Xylo-oligosaccharides 
2000 The Calpis Food Industry Co. (Japan) 
Suntory Ltd (Japan) 
Soya-oligo 
Xylo-oligo 
 
Both the volume and the diversity of oligosaccharide products are increasing 
rapidly as their functional proprieties become better understood (Crittenden et al., 
1996).   
There are many foods in which GOS can be included, such as bread and 
fermented dairy products. During yeast fermentation and the baking of bread, GOS 
are not decomposed and may influence positively the taste and the texture of the 
product. Fermented dairy products with Bifidobacteria spp. or other Lactic Acid 
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Bacteria (LAB) with added GOS are commercially available in Japan as well as in 
Europe.  
 
1.5 Galactooligosaccharides production in a research context 
Galactooligosaccharides produced by the action of β-galactosidase on lactose 
were identified for the first time in the early 1950s. Four species of GOS were formed 
using Kluyveromyces lactis β-galactosidase (Aronson, 1952; Pazur, 1954), and three 
using E. coli β-galactosidase (Aronson, 1952). Experiments conducted with high 
lactose concentrations detected eleven species of GOS (Roberts et al., 1957).  In the 
same study, the total concentrations of synthesised GOS was also quite high, as the 
hydrolysis of a 35% lactose solution contained up to 44% of the total sugar in the 
form of di- and higher- saccharides.  
Since then, there have been several studies of the enzymatic synthesis of GOS 
by β-galactosidase. The mains findings were that GOS production increased with 
initial lactose concentration (Wienbicki et al., 1973; Burvall et al., 1979) and that 
GOS production declined as the reaction progresses (Burvall et al., 1980). Also, 
different species of GOS were synthesized with different sources of enzyme, 13 
Lactobacillus strains showed that each enzyme produced a different spectrum of GOS 
(Toba et al., 1981), and more then 20 GOS species were found to be synthesized 
using Aspergillus oryzae β-galactosidase (Toba et al., 1985). Yang et al. (1988) 
indicated that trisaccharide GOS was formed for all reaction condition studied (lactose 
concentrations: 2.5, 5, 10, 15, 20 and 25%), whereas tetrasaccharide GOS was formed 
only when the starting lactose concentration was greater than 20%.  
A large number of studies to date have shown the formation of GOS using β-
galactosidase from different bacteria, such as Candida pseudotropicalis and 
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Kluyveromyces lactis (Jeon et al., 1984), S. fragilis (Toba et al., 1978), Escherichia 
coli (Huber et al., 1976), Aspergillus oryzae (Betschart et al., 1984) Penicillium 
chrysogenum (Ballio et al., 1960) and Bacillus circulans (Mozaffar et al., 1984) 
(Table 1.5).   
In the tables that follow, the percentage of maximum GOS on initial lactose 
used was calculated where possible. Otherwise, the maximum GOS was presented 
following the author reference.  
 
Table 1.5: Studies on transglycosylation reaction using lactose as substrate. Where 
Lac: lactose, E: enzyme, and Lac0: initial lactose concentration. 
Enzyme source [Substrate] and/or 
[Enzyme] studied 
Assay conditions Maximum 
synthesized GOS 
(% of  [Lac]0) 
Reference 
Saccharomyces fragilis [Lac]=50, 100, 150, 
200, 250, 300, 350, 
400 and 500 g/l 
 
[E]= 0.5 and 0.58% 
T=35°C in phosphate buffer 
(0.067M, pH 6.2) for 32 hours 
1.1-21.2% 
depending on  
[Lac] 
Roberts et al., 
1957 
Escherichia coli [Lac]=171g/l 
 
[E]=130µg/ml 
T=30°C in imidazole 
hydrochloride buffer (pH 7.2) 
with 0.01M NaCl and 
0.0067M MgSO4 for 14 hours 
~20% Huber et al., 
1976 
Bacillus circulans [Lac]=45.6 g/l 
 
[E]= 3U/ml 
T=40°C in buffer (pH 6.0) for 
5 hours 
6% Mozaffar et 
al., 1984 
Candida pseudotropicalis 
and Kluyveromyces lactis 
[Lac]=50 and 200 g/l 
 
[E]=1.0-2.0 U/ml 
T=37°C in phosphate buffer  
(0.25M, pH 6.6) for 4 hours 
with gentle agitation or at 
T=4°C for 24 hours 
11.3-16.3% 
depending on 
[Lac] and [E] 
Jeon et al., 
1984 
Aspergillus niger [Lac]=25, 50, 100, 
150, 200 and 250 g/l 
 
[E]=1.25 mg/ml 
T=50°C in buffer  ~10% Yang et al., 
1988 
 
Most recent studies of GOS production by β-galactosidase are focused on 
improving or maximizing GOS yields from lactose.  
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1.5.1 Research on GOS production using thermophilic enzymes. 
At high temperature lactose solubility increases and the viscosity of the media 
decreases which eliminates the possibility of microbial contamination of the reaction 
system. Thus transglycosylation reaction with high lactose content can be performed. 
Hence, enzymes that act at high temperatures can be used under conditions that favour 
GOS production (Table 1.6).  
 
Table 1.6: Transglycosylation reaction of lactose carried out with thermophilic 
enzymes. Where Lac: lactose, E: enzyme, and Lac0: initial lactose concentration. 
Enzyme source [Substrate] and/or 
[Enzyme] studied 
Assay conditions Maximum synthesized 
GOS (% of  [Lac]0) 
Reference 
Saccharopolyspora 
rectivirgula strain V2-2 
[Lac]= 599 g/l 
 
[E]=not well specified 
T=70°C in buffer (pH 
7.0) for 22 hours  
41%  Nakao et al., 
1994 
Sulfolobus solfataricus 
(SsβGly) and 
Pyrococcus furiosus 
(CelB)  
[Lac]= 70, 170 and 
270 g/l 
 
[E]= 20 U/ml 
T=70°C in sodium 
citrate buffer (20 mM, 
pH 5.5), with agitation 
(400 R.P.M.) 
Depending on [Lac]: 
~14, 23, 33% for 
Pyroc. furiosus 
~7, 17, 26 g/l for Sulfol. 
solfataricus 
Petzelbauer et 
al., 2000 
Sulfolobus solfataricus [Lac]= 300, 400, 500 
and 600 g/l  
 
[E]= 1.2, 2.4, 3.6 and 
4.8 U/ml 
T=70, 75, 80, 85 and 
90°C in phosphate 
buffer (50 mM, pH 
6.0) for 25, 60 and 80 
hours 
~52% after 
optimization of [Lac], 
[E], T°C, pH and 
reaction time. 
Ha-Young et al., 
2008 
Thermotoga maritima   [Lac]= 200, 300, 400 
and 500 g/l 
 
[E]= 1.0, 1.5, 2 U/ml 
T=50-100°C in 
phosphate buffer (50 
mM, pH 6.0) for 360 
minutes 
~ 10-18% depending on 
[Lac] and [E] 
 
Eun-Su et al., 
2005 
Sirobasidium magnum 
CBS6803 
[Lac]= 20 g/l 
 
[E]= 0.25 U/dl 
T= 60°C in sodium 
acetate buffer (100 
mM, pH 5.0) 
27%  Onishi et al., 
1997 
 
For some β-galactosidase, such as Sulfolobus solfataricus, it was found that 
GOS production increased linearly with temperature (30-95ºC) (Pisani et al., 1990). 
However, temperature did not influence some other enzymes, such as Aspergillus 
niger β-galactosidase, as oligosaccharides production was found to be constant 
between 8-50ºC (Yang et al., 1988). 
 
_____________________________________________________Chapter 1: Introduction 
 32
1.5.2 Research on GOS production using immobilized enzymes. 
Immobilization is important in commercial enzymology allowing the 
repetitive and economic utilization of enzymes (Oliveira et al., 2008). Compared with 
free enzyme in solution, enzyme immobilized on a solid support provides many 
advantages, including β-galactosidase reusability, continuous operation, controlled 
product formation, and simplified and efficient processing (Albayrak et al., 2002). For 
these reasons, there are studies focused on the immobilization of enzymes on a 
stationary phase while substrate is continually fed through the reaction medium (Table 
1.7). Consequently an appropriate immobilized system for transglycosylation is 
desirable (Petzelbauer et al., 2000).  
 
Table 1.7: Transglycosylation reactions of lactose carried out with immobilized 
enzymes. Where Lac: lactose; E: enzyme; FE: free enzyme; IE: immobilised enzyme, 
and Lac0: initial lactose concentration. 
Enzyme source [Substrate] and/or 
[Enzyme] studied 
Assay conditions Maximum 
synthesized GOS 
(% of  [Lac]0) 
Reference 
Thermus aquaticus 
YT-I free (FE) and 
immobilized (IE) 
[Lac]= 160 g/l 
 
[E]= 100 ml (IE) 
T=70°C in buffer (pH 4.6, 6.0) 
with agitation (60 R.P.M.) 
with FE: 
-32.8% at pH 6.0; 
- 32.4% E at pH 4.6; 
with IE: 
-32.7% at pH 6.0; 
-34.8% at pH 4.6 
Berger et 
al., 1995 
Aspergillus oryzae 
free (FE) and 
immobilized (IE) on 
cotton cloth in a 
recycle batch 
reactor 
[Lac]=43, 133 270 g/l (FE), 
2.7 g/l for (IE) 
 
 
[E]= 4.5, 11.8, 23.6 g/l (FE), 
5 mg/ml (IE)  
T=40°C in acetate buffer (0.1 
M, pH 4.5) for 15, 30 and 50 
minutes with shaking (150 
R.P.M.) 
~ 22% FE,  
~ 20% IE 
 
Matella et 
al., 2006 
Aspergillus oryzae 
free (FE) and 
immobilized (IE) on 
mPOS-PVA 
[Lac]= 50, 100, 200, 300, 
400, 500 g/l 
 
[E]= 0.149 mg/ml (FE), 0.383 
mg/ml (IE) 
T= 30, 40, 60 °C in citrate-
phosphate buffer solution (20 
mM, pH 3.5, 4.0, 4.5, 5.0, 5.5) 
26.1% FE 
26.0% IE 
Neri et al., 
2009  
Escherichia coli in 
reverse micelles  
[Lac]= 22.11 g/l in 
AOT/isooctane, 22.11 g/l and 
238 g/l in aqueous system   
 
[E]= 16.7 µg/ml in 
AOT/isooctane, 16.7 and 18 
µg/ml in aqueous system    
T= 37°C in buffer with 
338mM AOT/isooctane, 
36mM 2-mercaptoethanol and 
0.6mM MgCl2, (pH 4.3–11.2); 
T=37°C in aqueous system 
with Tris–HCl buffer (0.1M, 
pH 7.3) 
~ 5-10% depending 
on the conditions 
Chen et al., 
2003 
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Kluyveromyces 
lactis (Maxilact LX 
5000) immobilized 
on cotton cloth 
[Lac]= 30, 50, 75, 100 and 
125 g/l, pumped at flow rate 
2.8 ml/min 
 
[E]= 280U 
T= 37°C in potassium 
phosphate buffer (0.1 M, pH 
6.6) with MgCl2 (1.5 mM) for 
60-120 minutes 
2-18 mM depending 
on [Lac] 
Zhou et al., 
2003 
Saccharomyces 
cerevisiae L1, 
Penicillium 
expansum F3 and 
Kluyveromyces 
lactis L3 
immobilized in 
calcium alginate 
[Lac]= 50, 100, 180, 270, 
320, 380, 450 and 480 g/l 
 
[E]= 10U of immobilized E 
T= 37, 45, 50 and 55°C in 
acetate buffer (pH 3.6, 4.5, 
5.4) and phosphate buffer (pH 
6.4, 7.2, 8.2) for 24 hours 
28.7% for P. 
expansum F3; 
28.3% for S. 
cerevisiae L1; 
23.0% for Kl. lactis 
L3; 
Li et al., 
2008 
Aspergillus oryzae 
immobilized on 
cotton cloth 
[Lac]= 50, 100, 200, 300, 400 
and 500 g/l at flow rate 1 
ml/min 
 
[E]= 50 mg/g of cotton cloth 
T= 30, 40, 50°C in acetic acid 
buffer (0.1M, pH 4.5, 5.2, 6.0) 
for 11-25 hours depending on 
T°C incubation 
~ 26%  Albayrak et 
al., 2002 
 
The state of the enzyme (free vs. immobilized) appears to affect GOS 
formation. Some authors reported enzyme inactivation during the immobilization 
procedure and/or after use versus the free form: ~50-90% on polyethyleneimine and 
glutaraldehyde for a β-galactosidase from Aspergillus oryzae (Matella et al., 2006); 
~50% on silica-alumina for a β-galactosidase from Kluyveromyces fragilis (Ladero et 
al., 2000). This change may be due to mass transfer limitations for the larger sugar 
molecules (Yang et al., 1988). On the other hand, some authors (Berger et al., 1995; 
Neri et al., 2009; Gaur et al., 2006) did not find significant inactivation of the enzyme 
when immobilized or found that the immobilized enzyme gave a higher yield of GOS. 
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1.5.3 GOS production using different substrate concentrations or assay 
conditions 
Other researches have focused their studies on the effect of substrate 
concentration on GOS production without changing enzyme concentration or assay 
conditions, such as temperature, pH, agitation, reaction time (Table 1.8). 
 
 
Table 1.8: Transglycosylation reaction carried out with different lactose 
concentrations and fixed assay conditions. Where Lac: lactose, E: enzyme Lac0: initial 
lactose concentration. 
Enzyme source [Substrate] and/or 
[Enzyme] studied 
Assay conditions Maximum 
synthesized GOS 
(% of  [Lac]0) 
Reference 
Kluyveromyces 
lactis expressed 
in Escherichia 
coli 
[Lac]= 51.63, 95.84, 301.22 
g/l 
 
[E]= 0.029 mM 
T= 37 °C for 5 hours, in 
potassium phosphate buffer 
(50mM, pH 7.0), containing 
10mM NaCl and 1.5mM 
MgCl2 
~ 6-16% depending 
on [Lac] 
Kim et al., 
2004 
Bifidobacterium 
bifidum NCIMB 
41171 
[Lac]= 45, 55 g/l 
  
 
[E]= 2.5% (344U/g) 
T= 40°C with shaking (100 
R.P.M) for 25 hours, in 
phosphate buffer (0.1M, pH 
6.8) or citric acid/trisodium 
citrate (0.1 M, pH 6.2) 
~10-17% depending 
on [Lac] 
Goulas et al., 
2007 
Bifidobacterium 
bifidum NCIMB 
41171 
[Lac]= 100-500 g/l 
 
[E]= 2x108 c.f.u. 
T=39°C in potassium 
phosphate buffer (0.2 M, pH 
6.8) for 7 hours 
5% Tzortzis et al., 
2005 
Bacillus 
circulans 
[Lac]=~0.l9-0.59 g/l  
 
[E]= 0.4g in 2 ml H20 
T= 40°C in sodium 
phosphate buffer (0.02M, pH 
5) for 90-340 min 
~20-26% depending 
on [Lac] 
Boon et al., 
1999 
Aspergillus 
oryzae 
[Lac]= 47.57, 90.15, 191.68, 
359.97, 571.64 g/l 
 
[E]= 0.1% (4.2 U/ml) 
T= 40°C in  pH 4.5 for 15 
min 
~11-35% depending 
on [Lac] 
Iwasaki et al., 
1996 
Bifidobacterium 
infantis HL96, 
expressed in 
Escherichia coli 
[Lac]= 20-30 g/l 
 
[E]= 2.5 U/ml 
T= 30-60°C in Na-phosphate 
buffer (50 mM, pH 7.5) for 
30 hours with agitation (100 
R.P.M.) 
6% Hung et al., 
2002 
Bifidobacterium 
bifidum  
[Lac]= 34.23, 85.57, 117.14 
and 136.92 g/l 
 
[E]= 25 µl (50munits) 
T= 45°C in sodium citrate 
buffer (0.1 M, pH 4.25) for 
50 hours 
29% Dumortier et 
al., 1994 
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Others attempts to improve GOS synthesis examined the effect of lactose and 
enzyme concentrations or sources, or assays conditions, such as temperature, solvent 
or added metal cations (Table 1.9). 
 
Table 1.9: Transglycosylation reaction carried out with different lactose, and/or 
enzyme concentrations, and/or enzyme source, and/or assay conditions. Where Lac: 
lactose; E: enzyme; STR: stirred tank reactor; UFMR: ultra filtrate membrane reactor, 
and Lac0: initial lactose concentration. 
Enzyme source [Substrate] and/or 
[Enzyme] studied 
Assay conditions Maximum 
synthesized GOS 
(% of  [Lac]0) 
Reference 
Kluyveromyces 
lactis (Lactozym 
3000 L HP G) 
[Lac]= 150, 250, 350 g/l 
 
[E]= 3, 6, 9 U/ml 
T= 40, 50, 60°C in  phosphate 
buffer (50 mM, pH 5.5, 6.5, 7.5) 
with shaking at 300 rpm 
~ 5-17.1% depending 
on [Lac] and pH 
Martinez-
Villaluenga 
et al., 2007 
Aspergillus 
oryzae 
[Lac]= 51.34 g/l 
 
[E]= 0.025 mg (>8U/mg) 
T= 40°C in citrate buffer (50 mM, 
pH 4.5) or mixture organic solvent 
(1,4-butanediol, 1.5-pentanediol, 
methoxyethyl acetate, triethyl 
phosphate, acetonitrile) for 48 
hours 
~ 0.25-25% on 
lactose substrate at 
T0, depending on the 
solvent used 
Srisimarat et 
al., 2008 
Kluyveromyces 
lactis (Maxilact 
LX 5000) 
Reconstituted dried 
buttermilk, whose [Lac]= 
219 g/l  
 
[E]= 0.1, 0.4, 0.8, 1.2, 1.6, 
2% 
T= 38°C for 80 min ~ 13%  Čurda et al., 
2006 
Bifidobacterium 
bifidum 
truncated  
produced in E. 
coli 
[Lac]= 100, 200, 400 g/l 
 
[E]= not specified, different 
[E] used 
T= 38°C for 20 hours ~ 38-42% depending 
on the [Lac] 
Jørgensen et 
al., 2001 
Kluyveromyces 
maxianus var. 
lactis OE-20 
[Lac]= 10, 39, 50, 100, 200 
g/l  
 
[E]= 1.0 U/ml 
T= 25-40°C in phosphate buffer 
(10 mM, pH 7.0) for 3 hours 
1.5-13% depending 
on [Lac] and T °C 
Kim et al, 
2001 
Sterigmatomyces 
elviae  CBS8119 
[Lac]= 20 g/l 
 
[E]= 5 ml of toluene-treated 
suspension cells 
T= 60°C in potassium phosphate 
buffer (100 mM, pH 6.0) for 2 
hours 
24% adding Fe2+, 
Zn2+ and Cu2+ in the 
media 
Onishi et al., 
1998 
Kluyveromyces 
lactis (Maxilact 
L2000) in stirred 
tank reactor 
(STR) and cross-
flow 
ultrafiltration 
membrane 
reactor (UFMR) 
[Lac]= 220, 280, 340 and 
400 g/l in STR, 0.25 g/l in 
UFMR 
 
[E]= 2.9, 5.8 and 8.7 U/ml 
in STR, 8 U/ml in UFMR 
T= 40°C in potassium phosphate 
buffer (0.2M, pH 7.0) with MgCl2 
(2mM) for 4 hours with agitation 
(200 R.P.M.) 
in STR: 
 ~22-25% depending 
on [Lac] for [E]= 
5.8U/ml in STR; 
 ~ 70-100 mg/ml 
depending on [E] for 
[Lac]= 340 mg/ml;  
in UFMR: 
26.05 mg/ml with 
[Lac]=250 mg/ml 
Chockchaisa
wasdee et 
al., 2005 
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Penicillium 
semplicissimus 
 
 
 
[Lac]= 200, 300, 400, 500 
and 600 g/l  
 
[E]= 18 and 26.6 U 
T= 40, 45, 50 and 55°C in 
McIlvaine buffer (75 and 150 mM, 
pH 2.6-7.0) for 8 hours 
 25.63-30-48% 
depending on T °C 
and [Lac] 
Cruz et al., 
1999 
Bacillus 
circulans, 
Aspergillus 
oryzae, 
Kluyveromyces 
lactis, K. fragilis 
[Lac]=~ 0.20-0.60 g/l 
 
[E]= 62.5 mg/ml for B. 
circulans and A. oryzae, 100 
µl for K. lactis, 75 µl for K. 
fragilis 
T= 40°C for 360 min 
- in McIlvaine standard citrate 
buffer (0.02 M) pH 4.5 for A. 
oryzae and pH 5.0 for B. circulans; 
 
- in potassium phosphate buffer 
(0.025 M, pH 7.3) for K. lactis and 
pH 6.5 for K. fragilis; 
~ 8-15% depending 
on the source of the 
enzyme 
Boon et al., 
2000 
Kluyveromyces 
marxianus 
ATCC 56497, 
Kluyveromyces 
lactis, 
Aspergillus 
oryzae, Bacillus 
spp. 
[Lac]= 330 g/l 
 
[E]=1% (w/v) K. marxianus, 
10 and 13 U/g Lac for K. 
lactis, 6.2 U/g Lac for A. 
oryzae,  4.5 and 5.6 U/g Lac 
for Bacillus spp. 
T= 30, 40 and 50°C  with agitation 
(200-300 R.P.M.) for 24 hours; for 
Bacillus spp. 15U gluzyme/g Lac 
were added to the β-galactosidase 
at 0, 6, 12 and 18 hours and T= 
50°C pH 5.0 by adding 40% (w/w) 
CaCO3; for K. marxianus 1% (w/v) 
of malt extract was added, T= 30 
°C pH 5.0-5.5 by 5mM NaOH 
A. oryzae: 17-21%; 
K. lactis: 21-35%; 
Bacillus spp.: 27-
33%; 
K. marxianus ATCC 
56497: ~6% 
trisaccharides and ~ 
15% tetrasaccharides 
Cheng et al., 
2006 
 
Studies on laboratory selected bacterial enzymes have been also carried out 
(Table 1.10), without changing the assay conditions (temperature and pH). 
 
Table 1.10: Transglycosylation reactions carried out with selected bacteria or 
uncommon strains enzymes. Where Lac: lactose, E: enzyme, and Lac0: initial lactose 
concentration. 
Enzyme source [Substrate] and/or 
[Enzyme] studied 
Assay conditions Max 
synthesized 
GOS                
(% of  [Lac]0) 
Reference 
Sporobolomyces 
singularis  
[Lac]= 200 g/l 
 
[E]= 0.16 U/ml 
T= 40°C in phosphate 
citrate buffer (50 mM, pH 
6.0)  
~ 35% Ishikawa et al., 
2005 
Sterigmatomyces elviae 
CBS8119 
[Lac]= 400 g/l T= 30°C in buffer (pH 6.0, 
with (NH4)2SO4, K2SO4, 
KH2SO4, MgSO4, CaCO3) 
with shaking for 60 hours. 
~ 37.5%  Onishi et al., 
1995 
Penicillium 
semplicissimum 
[Lac]= 600 g/l  
 
[E]= 26.6 U/50 ml 
T= 50°C  in McLlvaine 
buffer (150 mM, pH 6.5) for 
8 hours 
30.5% Cruz et al., 
1999 
Bullera singularis Pure lactose and whey, 
whose [Lac]= 200 g/l 
 
[E]= 5.4 U/g Lac 
T= 37°C  in sodium 
phosphate buffer (50 mM, 
pH 6.0) for 30 hours 
34-41% Cho et al., 
2003 
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The proportion of transgalactosylation to hydrolysis reactions varies, 
depending on different sources of the enzymes. Some β-galactosidases, from E. coli 
or Aspergillus niger, appear to promote strong hydrolytic activity, whereas the β-
galactosidase from Aspergillus oryzae or Bacillus circulans exhibit strong 
transglycosylation (Mahoney, 1998). 
From the analysis of most of the present literature until now, it is possible to 
conclude that only a few researchers claim to have reached GOS synthesised level 
higher than 40%, while most of the research reached a GOS synthesis of around 20-
25%. The production of higher levels of GOS is a challenge and may require new 
approaches.  
Although the enzymes derived from various microbial origins have different 
properties, many use glutamic acid, as a key catalytic residue of their active site, as 
shown in Table 1.11. 
 
Table 1.11: Physical properties and catalytic residues of β-galactosidases from 
various microbial origins (Adapted from Zhou et al., 2001). 
Enzyme Origin Kluyveromyces lactis Escherichia coli  E. coli (subunits) Aspergillus niger 
Molecular weight (Da) 117618 116351 118016 119160 
Length (AA) 1025 1023 1031 1006 
Proton donor Glutamate482 Glutamate461 Glutamate449 Glutamate200 
Nucleophile/base Glutamate551  Glutamate537 Glutamate512 Glutamate298 
 
Several β-galactosidases have been purified, sequenced and extensively 
characterized. Some β-galactosidases are commercially available. Although there may 
be sequence differences in enzymes across species, the active site and the two 
catalytic glutamate residues are highly conserved. Thus, fundamentally the problem of 
enhancing GOS synthesis is to influence attack of sugar rather then water on the 
enzyme-galactose complex. 
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1.6 Modelling of GOS production kinetics 
Modelling the synthesis of galactooligosaccharides has been investigated in 
the past by different authors. Some authors (Iwasaki et al., 1996) considered the chain 
length of the synthetised galactooligosaccharides, involving a complex model based 
on 19 ordinary differential equations. Although a separation of GOS considering the 
chain length is the most complete approach to describe transglycosylation reaction, 
from a theoretical point of view, the application of the model could be difficult and 
lead to ill conditioned systems (Boon et al., 1999). 
Other authors (Boon et al., 1999 and 2000; Neri et al., 2009) proposed 
simplified mechanisms, with the consideration of the GOS family of compounds as a 
single moiety and ignoring the formation of allolactose or other intermediate 
compounds. The solution of the presented models involved the application of the 
King-Altman method (King et al., 1956) to simplify the system and reduce the 
number of equations. However, the King-Altman simplification lead to a model where 
the enzyme concentration is not considered as interactive part of the 
transglycosylation reaction.  
Kim et al. (2004) proposed a GOS reaction mechanism that included the 
enzyme concentration as well as the synthesis of allolactose in the system.  
To date, and to the best of our knowledge, no error associated to the estimated 
kinetic reaction rates has been reported in literature, other than the values reported by 
Neri et al. (2009) and Boon et al. (1999 and 2000). The procedure employed to report 
the parameters was to estimate the parameter and its standard error as the mean and 
the standard deviation of a series of individual fittings. With present statistical 
methods available it would be possible to report statistical errors from individual 
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experiments by applying a multiresponse nonlinear regression method (Bates et al., 
1984). 
 
1.7 Overview of the literature on GOS production by β-galactosidase 
Although there has been extensive research on better utilization of whey 
derived lactose, the dairy industry is still in need of new technologies for converting 
lactose into marketable products (Yang et al., 1995). Thus, converting lactose into a 
product that contains a prebiotic food ingredient and is free of problems associated 
with lactose intolerance is highly desirable (Playne et al., 1996). A recent study (Cho 
et al., 2003) comparing the transglycosylation reaction using pure lactose and cheese 
whey as substrate, found out that GOS conversion (%) and reaction rate of the whey 
reaction were slightly higher with cheese whey than when pure lactose was used as 
substrate. 
The β-galactosidase most studied for GOS production is from Escherichia coli 
and is encoded by the lacZ gene. It is not considered suitable for use in foods owing to 
toxicity problems associated with the host coliform (Mahoney, 1997). Hence, the β-
galactosidase from E. coli is generally not preferred for use in food industry (Joshi et 
al., 1987; Stred’ansky et al., 1993; Mahoney, 2003). Furthermore, many of the 
enzymes used in previous studies (Table 1.10) are not from sources commercially 
available or are not available in sufficient quantities for industrial applications. 
In contrast, relatively little is known about the enzymes from eukaryotes, 
such as Kluyveromyces lactis. Previous studies showed that β-galactosidase from B. 
circulans produces the largest sized oligosaccharides (Neri, 2008). However, the 
enzyme from Kluyveromyces spp. produces comparably large amounts of glucose and 
galactose as indicated by its strong hydrolytic activity and production of high 
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proportion of trisaccharides in the synthesis mixture (Boon et al., 2000; Matsumoto et 
al., 1993; Nakanishi et al., 1983; Prenosil et al., 1987). A recent study (Cheng et al., 
2006) compared GOS production by β-galactosidases from Aspergillus oryzae, 
Kluyveromyces lactis and Bacillus spp., in a combined system with K. marxianus β-
galactosidases, found that K. marxianus, increasing the final mass production of GOS 
by 3%. This is because more GOS-4 and less GOS-2 are obtained by the mixed 
enzyme system, as GOS-2 is consumed by K. marxianus, while GOS-4 is not.  
 
1.8 Objectives and aims of the work 
The aim of the research in this thesis is to investigate GOS production with 
commercially available β-galactosidases with a view to understanding the factors that 
influence GOS yield. In order to achieve this the following objectives of the work 
were: 
• To propose a model of the reaction system of GOS production that can 
be identified under normal conditions. 
• To investigate the effect factors that may influence and improve the 
GOS yield. As such the enzyme concentration, substrate concentration 
and solvent usage in the kinetics of GOS production were investigated. 
• To investigate the standardisation of GOS production research assays 
and the influence of the enzyme source in the GOS kinetics and yield.  
 
The enzymes were obtained from Kluyveromyces spp. and Escherichia coli. 
The substrate of the reaction was a waste by-product of the dairy industry, Whey 
Permeate. This material has recently been shown to be a good substrate for GOS 
synthesis (Cho et al., 2003).  
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We sought in the first place to devise an assay method that would allow rapid, 
convenient monitoring of the GOS synthesis reaction progress and the quantitation of 
key components using Thin Layer Chromatography, TLC. 
In order to quantify the GOS synthesis reaction products with greater accuracy 
and precision we devised a High Performance Liquid Chromatography (HPLC) assay 
method. This allowed accurate quantitation of reaction component profiles that were 
used to compare assays under different enzyme and substrate concentrations. 
Furthermore, it was possible to examine the effect of enzymes from different species, 
such as Kluyveromyces spp. and Escherichia coli, on the GOS synthesis with the aim 
of identifying those that gave higher yields.   
In order to reduce the water activity of the system, we have examined the 
influence of water miscible solvents on GOS synthesis. 
Finally, a reaction scheme for lactose hydrolysis and GOS production based 
on transglycosylation mechanisms previously described in the literature was proposed 
in order to construct a mathematical model of the experimental data. The reaction 
mechanism modelling will allow for: 
1. The analysis of yield and mass balance and thereby assess the efficacy 
of analytical methods to monitor the reaction progress. 
2. The estimation of the reaction rate constants for the proposed 
mechanism that would facilitate prediction of GOS yield at any point 
in time during the reaction. 
3. The optimisations of the GOS yield using the model. 
4. The assessment of the effect of the manipulation of reaction conditions 
(i.e different enzyme/substrate concentration, solvent addition, and 
different enzyme source) on GOS production. 
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2 Materials and Methods 
2.1 Substrates 
 2.1.1 Whey permeate  
The Whey Permeate (WP), used as substrate for GOS synthesis in these, was 
provided by Kerry Group plc (Prince’s Street Tralee, Co. Kerry, Ireland). This 
product, a fine powder of pale yellow colour, is characterised by a lactose content of 
over 90%. The spray dried whey permeate provided was a demineralised WP (product 
code W469), whose mineral concentration has been reduced by Ion Exchange. This 
product has a lactose content of up to 92%, a protein content of 2.5%, and a fat and 
mineral content of 1% each.  
The whey was stored in a multi-walled paper sack with inner polyethylene 
liner to avoid moisture absorption, and kept in a cool dry store, odour free, with 
maximum humidity of 65%. The product is suitable for food industry use. 
 
  
2.1.2 β-galactosidases  
Two β-galactosidases were used to carry out transglycosylation reactions. The 
first is commercially available under the name Maxilact® and was provided by 
Carbon Group (Ringaskiddy, Co. Cork, Ireland). Maxilact L2000 (G003-MLT-991) is 
a purified liquid lactase preparation derived from the dairy yeast Kluyveromyces 
lactis. Its activity is ≥ 2,000 Neutral Lactase Units/g. A Neutral Lactase Unit is 
defined as the quantity of enzyme that will liberate 1.0 μmol of o-nitrophenol from o-
nitrophenyl β-D-galactoside at pH 7.0 and 37ºC. The enzyme is supplied as a glycerol 
solution. The other chemical components present in Maxilact L2000 and its 
microbiological properties are listed in the Table 2.0. Maxilact L2000 complies with 
the purity specifications of the FAO/WHO’s Joint Expert Committee of Food 
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Additives (JECFA), with the Food Chemical Codex (FCC) and with the guidelines for 
Food Enzymes of the Scientific Committee of Food (SCF) in the EU. 
 
Table 2.0: Chemical and microbiological properties of Maxilact L2000. 
 
 
 
 
 
 
 
 
 
 
The enzyme preparation was stored in its original sealed container at 4ºC, as 
specified in the data sheet for the product. Under these conditions the loss of activity 
was less then 1% per month. 
The second enzyme used in these studies was an Escherichia coli β-
galactosidase, purchased from Sigma-Aldrich. The bacterial β-galactosidase, grade 
VIII, was a lyophilized powder with an activity of 600-1200 units/mg, where one unit 
was defined as the quantity of enzyme that hydrolyzes 1.0 μmole of o-nitrophenyl β-
D-galactoside to o-nitrophenol and D-galactose per minute at pH 7.3 and 37ºC.  
 
 
 
 
Specification Value 
Heavy Metals ≤ 30 ppm (as Pb) 
Lead ≤ 5 ppm 
Arsenic ≤ 3 ppm 
Mercury ≤ 0.5 ppm 
Cadmium ≤ 0.5 ppm 
pH 7.0-7.5 
Glycerol ≥ 50% (vol/vol) 
Total bacterial count ≤ 10 in 1 ml 
Coliforms ≤ 30 in 1 ml 
Salmonella Absent in 25 ml 
Staphyloccoccus aureus Absent in 1ml 
Escherichia coli Absent in 25 ml 
Lysteria monocytogenes Absent in 25 ml 
Yeasts ≤ 10 in 1 ml 
Moulds ≤ 10 in 1 ml 
Antibioticy activity Absent by test 
Mycotoxins Absent by test 
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2.2 Chemicals 
All the chemicals, including the chromatography standards: maltotriose, 
lactose, galactose and glucose; all solvents, such as ethanol, methanol, butanol, 
acetonitrile acetone, diethyl ether, dioxane and sulphuric acid; Thin Layer 
Chromatography plates (Fluka, ref. no. 02599); micropipettes (Blaubrand®, 
intramark, 1-5 µL, catalogue number 708707); were supplied by Sigma-Aldrich 
(Dublin, Ireland). 
 
2.3 Commercially available GOS syrup used for comparison studies 
The synthesised products of the reaction were compared with the pre-biotic 
galactooligosaccharide syrup commercially available under the name Vivinal GOS® 
(Friesland Foods Domo®, P.O. Box 449, Zwolle, 8000 AK, The Netherlands). The 
typical composition of this product is 75% dry matter, of which 59% is GOS, 21% 
lactose, 19% glucose and 1% galactose. The chemical, physical and microbiological 
specifications of Vivinal GOS® are listed in Table 2.1. 
.  
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Table 2.1: Chemical, physical and microbiological characteristics of Vivinal GOS®. 
Where D.M.: dried matter; c.f.u.: colony forming units. 
Specifications Value 
Dried matter (D.M.) 74-76% 
Galactooligosaccharides Min 57% on D.M. 
Nitrogen Max 0.016% on D.M. 
Sulphated ash Max 0.3% on D.M. 
Lactose anhydrous Max 23% on D.M. 
Glucose anhydrous Max 22% on D.M. 
Galactose Min 0.8% on D.M. 
Viscosity 1000-5000 cPs 
Nitrite Max 2 ppm on D.M. 
pH 3.2-3.8 
Total plate count T=30ºC Max 3000 c.f.u./g 
Enterobacteriaceae Absent in 1 g 
E. coli Absent in 5 g 
Yeasts Max 50 c.f.u./g 
Moulds Max 50 c.f.u./g 
Staphylococci Coagulase + Absent in 1 g 
Salmonellae Absent in 25 g 
 
 
2.4 GOS synthesis reaction  
Laboratory scale reactions for GOS synthesis were carried out by dissolving 
demineralised Whey Permeate in phosphate buffer (0.1 M, pH: 6.8) to which β-
galactosidase at varying levels was added. As indicated by studies in the literature 
(Huh, 1990; Lopez-Leiva et al., 1995; Rustom et al., 1998), high lactose 
concentrations facilitate transglycosylation reactions. Therefore, the lactose 
concentration used was 200 g/l, corresponding to the maximum aqueous solubility of 
lactose. In addition to the concentration of 200 g/l, a higher concentration was tested. 
A concentration of 350 g/l was reached by adding the Whey Permeate to the buffer 
system at its boiling point in order to create a supersaturated solution.  
For GOS synthesis reactions were carried out in an Erlenmeyer volumetric 
flask immersed in a thermostatic bath (GRANT OLS2000) at 40°C, with agitation at 
80 r.p.m., in order to allow for continuous mixing of the media without the formation 
of air bubbles.  
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Typically, the reactions were carried out in a volume of 100 ml for five hours 
to ensure completion of the synthesis/degradation reaction. Triplicate samples (1 ml) 
were withdrawn every 30 minutes. The enzymatic reaction was quenched by boiling 
for 10 minutes, followed by frozen storage at -18°C.  
 
2.4.1 Use of solvents 
Reduced water activity (aw) may enhance the synthesis of GOS (Goulas et al., 
2007). Moreover, many enzymes have altered specificity in the presence of organic 
solvents. To enhance GOS synthesis the effect of adding solvents to the GOS 
synthesis reaction mixture assay was investigated. The solvents were used in 
relatively low concentrations, to avoid inhibiting enzyme activity. The solvents used 
were ethanol, acetonitrile, acetone, diethyl ether and dioxane.  
 
2.4.2 Enzyme comparison studies 
GOS synthesis reaction was carried out to compare two β-galactosidases from 
different sources were carried out. The enzymes compared were E. coli β-
galactosidase and Kluyveromyces lactis β-galactosidase (Maxilact L2000). Thus, these 
enzymes were sourced from a prokaryote and a eukaryote microorganism. The 
reactions were carried out by dissolving demineralised Whey Permeate (200 g/l) in 
phosphate buffer (0.1 M, pH 7.0) with agitation (80 R.P.M.). The concentrations used 
were 0.1 mg/ml and 0.2% for E. coli and Maxilact L2000 respectively. The initial 
rates of lactose degradation were used to normalise the enzymes to the same activity. 
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2.5 Methods 
2.5.1 pH measurement  
pH was measured using an Orion pH meter model 420A (Orion research Inc, 
Beverly, MA. US). The pH meter was calibrated with pH 4.0, 7.0 and 10.0 standard 
buffers before use. 
 
2.5.2 Water activity measurement 
Water activity was measured using an AQUALAB model 3 TE (Decagon 
Devices, Inc.), with the temperature of the internal chamber set as the assay 
temperature. Before measurement, the water activity of pure distilled water and 
activated charcoal were checked.  
 
 
2.5.3 Thin Layer Chromatography (TLC) 
The products obtained through enzymatic hydrolysis of Whey Permeate were 
analysed by Thin Layer Chromatography (TLC), using a silica gel matrix on Alu-foil 
TLC plate (20x10cm, 60 Å medium pore diameter).  
A small portion of the samples (1 µl), was diluted 1:10 and applied to a TLC 
plate by capillary injection with a disposable micropipette. The samples were applied 
over 1 cm from the bottom of the plate and, at least 1 cm from each other. 
Development of the TLC plate was carried out in the Twin Trough Chamber 
light-weight CAMAG® (20x10 cm, product number 022.5254, Mason Technology, 
Dublin, Ireland), at room temperature, under a fume hood. Before application of 
samples the TLC plate was placed in the chamber, which contained the solvent, for 
pre-equilibration (Figure 2.0). This step, called conditioning, took 1 hour and helped 
to increase the reproducibility of the analysis (CAMAG protocol A 07.3). 
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Figure 2.0: TLC development steps. Conditioning is shown on the left and 
development on the right (From CAMAG protocol A 07.3). 
 
The solvent system used to separate the carbohydrate mixture, of glucose, 
galactose, lactose and galactooligosaccharides, was a butanol/methanol/H2O 
(70:20:10 [vol/vol/vol]) mixture. 
When development was completed, plates were dried using a Qualivac vacuum 
oven at 100 °C and -760 mmHg for 2 minutes approximately. To visualise the 
separated carbohydrates the plates they were sprayed with a fine spray of 35% H2SO4 
in Ethanol. Finally, the plate was dried in a vacuum oven (100 °C and -760 mmHg) 
for 5 minutes. 
Since the retention factor depends on many variables, such as temperature and 
solvent composition, an internal standard of lactose, glucose and galactose at a known 
concentration was spotted on every TLC plate.  
The analysis of the plate was achieved by the scanning the developed TLC plate 
using a optical scanner (HP series 5300) and subsequent analysis with image analysis 
software (Image J, version 1.38X). 
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2.5.4 High Performance Liquid Chromatography (HPLC) 
High Performance Liquid Chromatography (HPLC) analysis was used to 
accurately quantify GOS synthesis products. 
HPLC was carried out using a SUPELCOGEL Ca2+ column (product no. 
5930-U), 30 cm x 7.8 mm I.D., and a flow rate of 0.5 ml/min. A column heater 
(Waters Temperature Control Module I and II) was used to maintain the column 
temperature at 80 º C. The column is a cation exchange resin consisting of sulfonated 
cross-linked styrene-divinyl benzene copolymer in the calcium form, of 9 μm 
particles diameter.  
The mobile phase used was distilled, ultrapure water (Waters Purification 
System Simplicity 185). The mobile phase was filtered through Nylon filter 
(MAGNA 0.22 micron, 47 mm) and degassed for 20 minutes in an ULTRAsonick 
bath 57X (NEY) before use. 
The detector used was a Refractive Index (RI) Detector (Waters 410), with an 
internal temperature of 34 ºC. 
For automatic injection, the injection volume used was 10 µl. When the manual 
injector was used, 60 µl was injected.  
Instrument control, data acquisition and analysis were performed using the 
Empower 2 Enterprise Build 2154 (2005, 2006) software. 
The samples for HPLC analysis were diluted 1:100 or 1:500 and filtered through 
a Nylon membrane (SUPELCO, 25 mm x 0.45µm) before injection.  
 
 
 
 
______________________________________________Chapter 2: Materials and Methods 
 50
2.6 Numerical methods 
Model building and individual fitting of data from each of the experiments 
were performed using JSim version 1.6.82 (Physiom Project, Washington) 
(Bassingthwaighte, 2000).  
JSim estimated the values of reaction rate constants by fitting the proposed 
kinetic models to the experimental data using a mixture of a non-linear steepest-
descent, and an adaptive nonlinear least-squares and SENSOP, a variant of the 
Levenberg-Marquardt algorithm (Chan et al., 1993).  
The global fitting of the model to the experimental data was performed using 
software built in Fortran 77, employing the subroutine DLSODA May 2005 version 
of the ODEPACK library (Hindmarsh, 1983) for simulation of the ordinary 
differential equations (ODE) system and the multiresponse nonlinear regression 
subroutine DODRC from the ODRPACK library (Boggs et al., 1992).  
The integration of initial value ODE systems resulting from mathematical 
modelling was performed using a multistep backward differentiation formula for stiff 
systems in ODEPACK and a implicit Runge-Kutta method of order 5 for stiff systems 
(RADAU5) in JSim. 
The ODRPACK package used a derivative of the Levenberg-Marquardt 
algorithm to perform the fitting of experimental data to a biochemical reaction model. 
JSim simulation settings are shown in Table 2.2. 
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Table 2.2: JSim simulation constants setting: JSim simulation ODE (a) and JSim 
fitting (b). 
 
 
 
 
The ODEPACK package was set with the following options shown in Table 2.3. 
 
 
Table 2.3: ODEPACK package constants setting. 
 
 
 
In the ODRPACK package Jacobian calculation was carried out by a central 
differences scheme. The precision of regression estimated automatically by 
ODRPACK is shown in Table 2.4. 
 
Table 2.4: ODRPACK precision of regression setting. 
 
 
 
 
 
 
 
 
 
JSim simulation ODE Value 
Relative tolerance 10-4 
Absolute tolerance 10-7 
Number of steps 100000 
JSim fitting Value 
Maximum number of iterations 2000 
Min RMS error 0.001 
Minimum gradient 10-6 
Parameter tolerance 10-8 
ODEPACK package Value 
Atoll 10-4 
Rtoll 10-7 
Number of steps 500000 
ODRPACK package Value 
Significant digits up to 8 
Tolerance of sum of squares 1.5x10-8 
Parameter tolerance 3.6x10-11 
Maximum number of iterations 10000 
(a) (b) 
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3 Results  
3.1 Development of a TLC method for analysis of GOS synthesis 
Thin Layer Chromatography (TLC) was initially explored as a screening 
technique to monitor the synthesis of GOS. This technique is simple, quick, and 
inexpensive. TLC offers the possibility of observing all the components in the 
synthesis of GOS at the same time. Thus, under suitable conditions, lactose, glucose, 
galactose and GOS may be monitored simultaneously. 
Different solvent systems were explored to achieve optimum spot resolution. A 
literature review identified several examples of previous studies of TLC analysis of 
sugars, carried out using different solvent systems.  
For example, Rabiu et al., (2001) separated carbohydrates mixtures, such as 
glucose, galactose, lactose and galactooligosaccharides, by TLC using butanol-
ethanol-water (5:3:2 [vol/vol/vol]) as the mobile phase. Petzelbauer el al., (2000), 
used 2-methyl-1-propanol/pyridine/H2O (6:4:3) as eluent. Jørgensen et al. (2001) used 
a solvent system containing butanol/2-propanol/H2O (3:12:4 [vol/vol/vol]); while 
Fischer et al. (2006) achieved separation of oligosaccharides in an acetone/n-
butanol/water (70:15:15) mixture. Ohmiya et al., (1977), analysed the products of 
lactose hydrolysis with an n-butanol/methanol/boric-acid TLC system (5:3:1 
[vol/vol/vol]) at room temperature. The CAMAG protocol (Materials and Methods, 
section 2.5.2) advised the use of a mixture of acetonitrile/H2O (85:15) for the analysis 
of mono-, di- and trisaccharides and a butanol/methanol/H2O system (50:25:20) for 
the separation of polysaccharides. 
In our hands, most of those solvent systems were found to yield unsatisfactory 
results in terms of resolution, mobility and streaking with the sugars used in this 
study. Our optimisation studies showed a solvent system composed of 
________________________________________________________Chapter 3: Results 
 53
butanol/methanol/H2O (70:20:10), achieved good resolution and minimised streaking.  
Equilibration of the TLC plate with the solvent system gas phase, prior to 
chromatographic development, was essential to achieve good resolution, using the 
CAMAG protocol (A 07.3, www.camag.com).  
To visualise the separated sugars on the TLC plate, different solutions may be 
used, such as: 5% ceric sulphate in 15% concentrated H2SO4 (Rabiu et al., 2001), 
orcinol reagent (Jørgensen et al., 2001), anthrone-H2SO4 reagent (Ohmiya el al., 
1977), 5% H2SO4 in ethanol containing α-naphtol (Tanriseven et al., 2002), 3% para-
anisaldehyde in ethanol containing 5% H2SO4 (Naudorf et at., 1998),  The 
visualization could be achieved either by dipping the plate into the  staining mixture 
or by spraying it. After several investigations, a solution of H2SO4 in ethanol was 
found to be the most appropriate detection mixture for these studies. However the 
concentration of H2SO4 was increased to 35% compared to literature protocols 
(Tanriseven et al., 2002; Naudorf et al., 1998; Rabiu et al., 2001). The visualization 
solution was sprayed on the TLC plates since this method gave a better visualization 
than the dipping method. 
TLC has been used as a qualitative method to detect galactooligosaccharides 
by many authors (Rabiu et al., 2001; Jørgensen et al., 2001; Ohmiya et al., 1977; 
Tanriseven et al., 2002; Petzelbauer el al., 2000; Naudorf et al., 1998), but not as a 
quantitative method. In this study we investigated the possibility of using this method 
to quantify components as they changed during GOS synthesis. 
Therefore, qualitative analysis of GOS synthesis was carried out by scanning 
TLC plates, followed by image analysis with Image J software. This program allows 
quantitative analysis of the spots on the TLC plates which are related to their darkness 
and area.     
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Standards solutions of glucose, galactose, lactose and maltotriose were spotted 
on TLC plates under the previously described conditions (Materials and Methods, 
section 2.5.3). The TLC plates showed a linear correlation between the concentration 
of the sugars and the darkness and area of the spot (Figure 3.0). 
 
 
 
 
 
Figure 3.0: TLC analysis of standard solutions. The densities of the spots of 
glucose, galactose, lactose and maltotriose standard solutions are proportional to their 
concentrations. Each starting point is a different concentration of a pure standard 
solution (line 1: 25 g/l; line 2: 16.6 g/l; lane 3: 12.5 g/l; lane 4: 6.25 g/l; lane 5: 5 g/l; 
line 6: 4.16 g/l). The TLC plates were developed with a butanol/methanol/H2O 
(70:20:10 [vol/vol/vol]) mixture, stained with a solution of 35% H2SO4 in ethanol and 
dried in a vacuum oven (100 °C and -760 mmHg) for 5 minutes.  
Galactose 
Lactose 
Maltotriose 
Glucose 
   
Lane no.    1       2       3        4       5       6        1        2        3      4       5       6        1       2       3       4        5        6 
     
 Lane no.     1       2      3      4      5     6         
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Data from the TLC plates shown in Figure 3.0, were used to construct 
calibration curves for lactose, galactose, glucose and maltotriose (4.16, 5, 6.25, 12.5, 
16.6 and 25 g/l) (Figure 3.1). Each calibration curve was constructed for six 
concentration levels, with each concentration spotted in triplicate.  
The response factor of maltotriose was used to calibrate 
galactooligosaccharides. There is not a commercial GOS available for calibration and 
because GOS is a heterogeneous mixture, maltotriose was the closest oligosaccharide 
to GOS available.  
Each TLC plate was run using an internal standard lane to correct for day to 
day variations in response to visualization staining. This mechanism allowed the 
reduction of the variability of each analysis due to factors such as: quantity of stain 
sprayed on the TLC plates, temperature and time of drying. The internal standards 
used were: (i) glucose which was used for the glucose calibration; (ii) galactose, 
which was used for the galactose calibration; and (iii) lactose which was used as 
internal standard for lactose and GOS. The reasons for using lactose as an internal 
standard instead of maltotriose is that it represented the variation in the assay in the 
same way as maltotriose, and was a cheaper alternative. 
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Figure 3.1: TLC standards calibration curves. Galactose, glucose, lactose and 
maltotriose curves are the average of the three replicates (± standard deviations). The 
linear trend line and relative R2 is shown.  
 
In all cases, calibration curves were linear over the range of concentrations 
used. However, it was apparent that the calibrations for monosaccharides were more 
reproducible than for lactose and maltotriose. Significant errors were associated with 
estimation of maltotriose and lactose concentration in particular. 
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3.1.1 Monitoring Maxilact-catalysed GOS synthesis from Whey Permeate by 
TLC 
The TLC assay method developed was used to monitor Maxilact-catalysed GOS 
synthesis form Whey Permeate. Maxilact is a commercial preparation of β-
galactosidase from Kluyveromyces lactis, which has been used previously by other 
authors for GOS synthesis (Zhou et al., 2003; Čurda et al., 2006; Chockchaisawasdee 
et al., 2004). Whey Permeate is not a very common substrate for GOS synthesis, pure 
lactose is more commonly used (Tables 1.5-1.10). 
Figures 3.2 and 3.3 show a typical TLC plate obtained for the synthesis of GOS 
using 0.1, 0.4, 0.8, 1.2, 1.6 and 2% Maxilact and a Whey Permeate solution (200 g/l) 
as substrate at 37 ºC over a 5 hour reaction time at pH 6.8. On each TLC plate an 
internal standard, composed of lactose, galactose and glucose at a fixed concentration 
(Control), has been spotted in the first lane.  
The assays with 0.1, 0.4, 0.8, 1.2, 1.6 and 2% Maxilact showed the typical 
profile described for GOS synthesis by other researchers (Čurda et al., 2006; 
Chockchaisawasdee et al., 2004). It was possible to separate and distinguish all 
components during GOS synthesis. The TLC analysis clearly shows lactose 
decreasing while GOS, galactose and glucose all increase.  
The TLC plates in Figures 3.2 and 3.3, show the influence of enzyme 
concentration on GOS synthesis. The reaction was monitored every 30 minutes for 5 
hours. For all concentrations used GOS formation was observed within 30 minutes. 
The spot corresponding to glucose is clearly visible from the beginning of the 
enzymatic reaction and the density of glucose spot is always denser than the galactose 
spot. This is consistent with the mechanism of the transglycosylation reaction (Figures 
1.4 and 1.6).  
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The heterogeneous nature of GOS species gives streaking of its spot in the TLC 
plates, making GOS estimation difficult. Resolution of GOS from lactose becomes 
more difficult as synthesis progresses (see Figure 3.2 and Figure 3.3). It is clear that 
GOS synthesis reaches a maximum whereafter it declines. This is clear that the 
enzyme hydrolyses GOS species and that degradation to monosaccharides is favoured 
as lactose concentration decline (Figure 3.3). By comparison of Figures 3.2 and 3.3, it 
is clear that the hydrolysis process is faster in Figure 3.3 due to the higher enzyme 
concentration used.   
In conclusion, comparing the assays of GOS synthesis at different enzyme 
concentrations revealed similar profiles and showed that the enzyme concentration 
influences the rate of the degradation of lactose and as a consequence, the production 
of GOS. 
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Figure 3.2: TLC analysis of GOS synthesis. Enzyme (E) concentrations: 0.1, 0.4 
and 0.8% respectively, using Whey Permeate as substrate. Samples were withdrawn 
every 30 min of the 5 hour reaction. Control was an internal standard composed of a 
mixture of lactose, glucose and galactose at 16.6 g/l, spotted in the first lane of every 
TLC plate. Each starting point is a consecutive sample of the reaction. 
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Figure 3.3: TLC analysis of GOS synthesis. Enzyme (E) concentrations: 1.2, 1.6 
and 2% respectively, using Whey Permeate as substrate. Samples were withdrawn 
every 30 min of the 5 hour reaction. Control was an internal standard composed of a 
mixture of lactose, glucose and galactose at 16.6 g/l, spotted in the first lane of every 
TLC plate. Each starting point is a consecutive sample of the reaction. 
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A comparison of the synthesised GOS in a sample assay (0.4% Maxilact) and 
the commercially available GOS solution (Vivinal GOS®) was carried out (Figure 
3.4). 
 
 
 
 
 
 
Figure 3.4: TLC comparison of synthesised GOS in a sample assay with a 
commercially available GOS source. It can be seen that the retention time of the 
GOS in the sample assay is the same of the GOS in Vivinal GOS® solution. 
 
The data from Figures 3.2 and 3.3 were analysed as indicated in Materials and 
Method’s chapter (section 2.5.3) and an attempt was made to quantify the changes in 
reaction species. The data are shown in Figure 3.5. 
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Figure 3.5: Quantitative analysis of GOS synthesis reaction progress. Assays 
were carried out in phosphate buffer (0.1M, pH 6.8) with Whey Permeate (200 g/l) at 
40ºC, for 300 minutes reaction time; enzyme concentrations used were: 0.1, 0.4, 0.8, 
1.2, 1.6 and 2% Maxilact (Where ▲: Lac, ▬: Glc, ٭: Gal, and ●: GOS). 
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From Figure 3.5, at 0.1 and 0.4% Maxilact concentrations, it appears that GOS 
synthesis reaches a maximum level. At higher enzyme concentrations, it is observed a 
maximum in GOS production is observed, followed by a slow decline due to the 
hydrolysis of GOS.  
Figure 3.6 shows how the enzyme concentrations influence the initial rate of 
lactose consumption. By increasing Maxilact concentration, the difference between 
the initial lactose and the lactose left after 30 minute of reaction increases. 
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Figure 3.6: Influence of enzyme concentration on lactose depletion rate. It can be 
seen how increasing doses of enzyme will increase the rate of lactose hydrolysis, 
therefore making this an enzyme catalysed reaction. 
 
From these data, it is clear that optimization of GOS production will require a 
thorough knowledge of the kinetics of the GOS synthesis reaction in order to identify 
the time at which GOS production is optimal for a given level of enzyme. 
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3.2 Mathematical modelling of the enzymatic synthesis assays 
3.2.1 Full reaction mechanism model 
The transglycosylation reaction mechanism could be described by the following 
equations (see equations 3.1-3.4 below) (Kim et al. 2004) (this model will be referred 
in all further discussion as the full model). 
This model was based on the following assumptions: 
- Any effect of diffusive transport has not been considered. 
- Only one rate-limiting step is involved in the reaction mechanism and all the 
other steps are reversible. 
- Lactose acts as both a substrate and a glycosyl acceptor, depending on its 
concentration. 
- Lactose binds the free enzyme to form the E:Gal complex, which interacts 
with lactose and glucose for the transglycosylation reaction, but not with 
galactose. 
- Glucose reacts with the E:Gal complex to form glucose-galactose 
disaccharides. 
- In order to estimate the molar concentration of GOS a molecular weight of 
504.32 g/Mol was assumed estimating a chain of 2 galactose with one 
glucose unit.      
- The β-galactosidase molecular weight was obtained from BRENDA (Tello-
Solís et al., 2005) and assumed to be 117619 Da. 
The model reaction mechanism is described below in equations (3.1) to (3.4) 
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E + Lac          E:Lac  k2⎯⎯⎯→    E:Gal + Glc                                                (3.1) 
 
E:Gal                              E + Gal                                                                                  (3.2)                      
 
 
E:Gal + Glc                            E + Allo                                                                          (3.3) 
 
 
E:Gal + Lac                                               E + GOS                                                                 (3.4) 
 
Where: E: enzyme; Lac: lactose; E:Lac: enzyme-lactose complex; E:Gal: enzyme-
galactose complex; Gal: galactose; Glc: glucose; Allo: allolactose. 
 
The material mass balances are described by the following equations (3.5) to 
(3.12): 
                                       
(3.5) 
                                       
                                       
                                                                                                                                  (3.6)                               
                                                                          
                                    (3.7) 
                                                                                                                             
                                                                                                                         (3.8) 
 
                        (3.9) 
                                                                                                                                 
                                                                                                                                (3.10) 
k1⎯⎯⎯→
rk 1
← ⎯
k3⎯⎯⎯→
rk 3
← ⎯
k4⎯⎯⎯→
rk 4
← ⎯
GlcGalEkAlloEkLacEk
dt
dGlc
r ⋅⋅−⋅⋅−⋅= :: 442
GOSEkLacGalEkAlloGalEk
GlcGalEkGalEkGalEkLacEkLacEk
dt
dE
rr
rr
⋅⋅−⋅⋅+⋅⋅−
−⋅⋅+⋅−⋅⋅+⋅+⋅⋅−=
554
43311
::
:::
LacGalEkGOSEk
GlcGalEkAlloEkGalEkGalEkLacEk
dt
GaldE
r
rr
⋅⋅⋅−⋅⋅+
+⋅⋅−⋅⋅+⋅⋅−⋅⋅+⋅=
55
44332 ::
:
k5⎯⎯⎯→
rk 5
← ⎯
LacEkLacEkLacEk
dt
LacdE
r ⋅⋅+⋅−⋅−= 112 :::
GalEkGalEk
dt
dGal
r ⋅⋅−⋅= 33 :
LacGalEkGOSEkLacEkLacEk
dt
dLac
rr ⋅⋅−⋅⋅+⋅⋅−⋅= :: 5511
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                                                                                                            (3.11) 
 
                                                                  
                                                                                                                                (3.12) 
 
The kinetic parameters k1, kr3, k4, kr4, k5 and kr5 are expressed in M-1min-1 and 
kr1, k2 and k3 are expressed in min-1. 
 
3.2.2 Fitting of GOS synthesis reaction using the full model 
The data obtained from the TLC analysis assays have been modelled using the 
full model: equations (3.1) to (3.4).  
Figure 3.7 shows a typical fitting of the TLC data using the full model 
(equations 3.1-3.5). The full model described the experimental data well. 
 
 
 
 
LacGalEkGOSEk
dt
dGOS
r ⋅⋅+⋅⋅−= :55
GlcGalEkAlloEk
dt
dAllo
r ⋅⋅+⋅⋅−= :44
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Figure 3.7: Measurement and model prediction with full model. HPLC assay with 
0.1% Maxilact in WP (200 g/l) is shown. Symbols are the points of experimental data 
and lines are the curve fits of the species for the proposed model. Where ○: Lactose; 
□: Glucose; : Galactose and ∆: GOS. Assay conditions are described in Materials 
and Methods (Section 2.4). 
 
Table 3.0 shows the fitted kinetic parameters obtained. However, a high 
correlation between the kinetic parameters was found and sometimes also a high 
standard error (Table 3.0).  
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Table 3.0: Fitted parameter values of the enzymatic assays with Maxilact (0.1, 0.4, 
0.8, 1.2, 1.6 and 2%) and Whey Permeate (200 g/l). All figures are mean ± standard 
deviation. 
Parameters 0.1%E         
200 g/l WP  
0.4%E          
200 g/l WP  
0.8%E         
200 g/l WP 
1.2%E        
200 g/l WP 
1.6%E        
200 g/l WP 
2%E        
200 g/l WP 
k1 (M-1min-1) 2052±3 1285±3 1721±8 1641±20 1478±6 1666±3 
kr1 (min-1) 23872±4 25459.1±0.5 25443±11 25447±10 25458±13 25707±3 
k2 (min-1) 3550±4 4178±2 1388±16 1268±14 2440±20 1580±2 
k3 (min-1) 1.3x103±6 x103 2859.2±1.7 3763±5 2786±2 2468±2 2861±6 
kr3 (M-1min-1) 139±2 703.6±1.0 419±25 375±3 877±3 406±7 
lk4 (M-1min-1) -15±2 -25±4 -17±10 -18±15 -26±30 -21±4 
kr4 (M-1min-1) 180±3 0.480±150 86±20 100±30 6.440±7 92±2 
k5 (M-1min-1) 7.2±1.6 3.1±0.9 4±1.5 3.6±0.7 1.7±0.6 2.1±0.7 
kr5 (M-1min-1) 687±3 55 ±7 43±7 48±3 77 ±10 50±3 
 
A significant difficulty when modelling of experimental data was encountered. 
This was largely due to the large errors associated with TLC measurement which 
made reliable estimates of GOS synthesis difficult. However, the TLC method was 
useful as a way to monitor trends of the reaction mechanism. 
Table 3.1 shows data for TLC analysis of GOS production at 0.4% Maxilact. 
 
Table 3.1: TLC results of the assays 200 of Whey Permeate (WP) with 0.4% 
Maxilact concentration. All figures are mean ± standard deviation. 
Time 
(min) 
GOS   
(g/l)  
Lactose 
(g/l)  
Glucose 
(g/l) 
Galactose 
(g/l) 
Total 
(%) 
0 0 198±5 0 0 100±5 
30 48±14 116±22 38±12 16±5 109±30 
60 77±28 71±18 48±11 23±5  111±36 
90 94±36 40±13 56±12 25±1.9 109±41 
120 115±29 31±9 63±13 31±2 121±33 
150 11±7 17±4 67±10 33±4 161±32 
180 106±33 14±4 75 ±19 37±1.0 118±38 
210 102±27 12 ±4 73±19 37±3 114±34 
240 107±23 9±5 79±20 42±5 120±32 
270 107±20 8 ±4 85±20 47 ±11 126±32 
300 95±29 6±3 91±24 44±12 119±39 
 
The large errors associated with the measurement of GOS species it made 
difficult to use the TLC assay for studies of reaction mechanism. In particular, there 
was an overestimation of GOS in comparison with literature (Zhou et al., 2003; Kim 
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et al., 2004). Based on this, it was decided to develop a HPLC method as a more 
precise and accurate way of monitoring the reaction. 
 
3.3 Development of HPLC assay to monitor GOS synthesis 
To solve the mass balance problem with TLC assay method, a HPLC method 
was devised. HPLC was carried out on a SUPELCOGEL Ca2+ column at 80 ºC, using 
distilled, ultrapure degassed water as the mobile phase at a flow rate of 0.5 ml/min. 
Components were monitored using a Refractive Index Detector. HPLC analysis gave 
more accurate and reproducible quantitation of the species in the GOS synthesis 
reaction mixture and a more reliable mass balance. However, the general trend of the 
reactions was the same as observed previously by TLC. 
The mass balances obtained with the HPLC method have a smaller standard 
deviation in comparison with the TLC method. The data obtained in a typical assay 
(0.4% enzyme), including the mass balance, are presented in Table 3.2. The total of 
the species present in the reaction is within 10% error of the starting value. Thus, the 
HPLC assay may be considered a more reliable method than TLC assay for the 
quantitation of the changing components of the GOS synthesis reaction. Monitoring 
using this assay is expected to yield data that are more suitable for modelling studies. 
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Table 3.2: HPLC results of the assays with different concentration of Whey Permeate 
200 g/l (a) and 350 g/l (b) with 0.4% Maxilact. All figures are mean ± standard 
deviation. 
 
 
 
Time 
(min) 
GOS       
(g/l)  
Lactose      
(g/l)  
Glucose 
(g/l) 
Galactose 
(g/l) 
Total      
(%) 
0 5.5±0.1 343±4 0 0 100.0±0.9 
30 26.8±1.4 292.9±1.4 38.±2 28.4±1.6 110.7±0.8 
60 60.6±0.9 230.4±0.9 63±2 39.9±0.8 113.0±1.5 
90 57.9±0.4 187.1±1.9 84.8±1.1 43.1±0.6 106±4 
120 66.4±0.7 166.7±0.9 102.4±1.2 60.2±1.4 113±2 
150 66.5±1.4 141.9±1.2 109.4±1.1 57.1±0.9 107±4 
180 75.3±1.6 136.2±0.6 127.2±1.7 67.7±1.3 116±3 
210 79.5±0.5 128.1±1.8 130.5±0.2 68.0±1.3 116 ±2 
240 77.7±1.4 123.8±1.5 131.6±1.7 70.2±2 115±2 
270 77.2±0.5 118.5±0.3 136.6±1.5 76.3±1.3 117±2 
300 68.5±1.1 109.8±0.5 134.2±0.2 80.7±1.4 112±2 
 
 
 
A typical chromatogram of the standard elution times for a solution of 
standards is presented in Figure 3.8. Maltotriose, used as reference for GOS because 
of its chemical structure, eluted at 10 minutes, followed by lactose (11 minutes), 
glucose (13 minutes) and galactose (14 minutes).  
 
 
 
 
Time 
(min) 
GOS       
(g/l)  
Lactose      
(g/l)  
Glucose 
(g/l) 
Galactose 
(g/l) 
Total      
(%) 
0 3.4±0.6 197.9±0.9 0 0 100.0±1.0 
30 22.4±0.5 108.9±0.3 52.3±0.3 30.09±0.7 106.24±1.0 
60 37.5±0.8 75.9±0.7 59.6±1.2 42.5±0.4 107.12±1.6 
90 29.3±0.3 56±3 68.3±1.5 49±2 100±3 
120 27.4±1 47.7±1.4 66.6±0.8 59.1±1.7 99±2 
150 31.4±1.7 50±2 76.9±1.9 50±2 103±4 
180 30.7±1.8 50±2 75.2±1.6 61±2 108±4 
210 29.3±0.9 46.6±0.6 76.5±1.9 64.1±0.6 107±2 
240 25.4±0.7 43.8±0.3  77±2 70.5±0.7 108±2 
270 23.8±0.9 37.3±0.3 76.2±0.8 74±2 105±2 
300 21.8±0.4 38.3±1.1 70.7±0.9 70.6±1.4 100±2 
(a) 
(b) 
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Figure 3.8: Typical HPLC profile for standards solution. The standard mixture 
retention times in minutes were: Maltotriose (Mlt) 9.9808; lactose (Lac) 11.188; 
glucose (Glc) 13.017; galactose (Gal) 14.176. Each component of the standard 
mixture was present at a concentration of 0.1 g/l. The standard mixture was eluted at 
0.5 mil/min using ultrapure, distilled and degassed water as mobile phase on a 
SUPELCOGEL Ca2+ column at 80 º C, and a RI detector. 
 
Although baseline resolution of peaks was not obtained, it was possible to 
obtain linear standard curves with a smaller standard deviation than those obtained 
using the TLC method. That was due to lower variability of HPLC methodology 
(Table 3.2, Figure 3.9) and to the favourable HPLC peak resolution (Figures 3.8 and 
3.9). 
Standard curves for maltotriose, lactose, glucose and galactose were carried 
out over a concentration range of 0.01-1.0 g/l (Figure 3.9) using the HPLC analysis 
method.  
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Figure 3.9: HPLC Standards calibration curves. Galactose, glucose, lactose and 
maltotriose are represented as average of the three replicates with their standard 
deviations. The linear trend lines, the equations and their relative R2 are also 
represented. 
 
A typical chromatogram obtained from a GOS synthesis reaction mixture is 
shown below at time 0 and after 210 minutes of reaction (Figure 3.10). Under these 
conditions, the first components to elute are oligosaccharides (GOS eluted at 10.69 
minutes), followed by disaccharides (lactose eluted at 12.06 minutes), then 
monosaccharides (glucose eluted at 14.02 minutes and galactose at 15.28 minutes).  
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Figure 3.10: Chromatograms of GOS synthesis at different reaction times. Assay 
with 0.1% Maxilact in Whey Permeate (200 g/l) at the beginning of the reaction (a) 
and after 210 minutes (b). Elution times at the beginning of the reaction: Lactose 
12.158 minutes. Elution times, in minutes, after 150 minutes of reaction:  GOS 10.69 
minutes; lactose 11.335; glucose 13.217; galactose 14.404. Where: Lac: lactose, Glc: 
glucose and Gal: galactose.  Samples eluted with 0.5 mL/min ultrapure, distilled and 
degassed water in a SUPELCOGEL Ca2+ column at 80 º C, RI detector. 
 
 
 
 
 
(a) 
(b) 
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3.3.1 GOS synthesis reaction mixture at different Maxilact and Whey Permeate 
concentrations 
Enzymatic assays with different Maxilact concentration (0.1, 0.4, 0.8, 1.2, 1.6 
and 2%) and Whey Permeate (200 and 350 g/l) were carried out (Figures 3.9, 3.10, 
3.11, 3.12). 
Comparing Figure 3.5 with Figures 3.11 and 3.12 it is possible to notice that 
TLC analysis caused an overestimation of the quantitation of some of the species in 
the reaction, especially GOS.   
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Figure 3.11: Quantitative analysis of GOS synthesis at different Maxilact 
concentrations. Assays were carried out in phosphate buffer (0.1 M, pH 6.8) with 
Whey Permeate (200 g/l), at 40ºC, for 300 minutes reaction; enzyme concentrations 
used were 0.1, 0.4 and 0.8 % Maxilact. (Where ▲: Lac, ▬: Glc, ٭: Gal, and ●: GOS) 
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Figure 3.12: Quantitative analysis of GOS synthesis at different Maxilact 
concentrations. Assays were carried out in phosphate buffer (0.1 M, pH 6.8) with 
Whey Permeate (200 g/l), at 40ºC, for 300 minutes reaction; enzyme concentrations 
used were 1.2, 1.6 and 2 % Maxilact. (Where ▲: Lac, ▬: Glc, ٭: Gal, and ●: GOS) 
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Figure 3.13: Influence of increased lactose concentration on GOS synthesis at 
different Maxilact concentrations. Assays were carried out in phosphate buffer (0.1 
M, pH 6.8) with Whey Permeate (350 g/l), at 40ºC, for 300 minutes reaction; enzyme 
concentrations used were 0.1, 0.4 and 0.8 % Maxilact. (Where ▲: Lac, ▬: Glc,        
٭: Gal, and ●: GOS) 
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Figure 3.14: Influence of increased lactose concentration on GOS synthesis at 
different Maxilact concentrations. Assays were carried out in phosphate buffer (0.1 
M, pH 6.8) with Whey Permeate (350 g/l), at 40ºC, for 300 minutes reaction; enzyme 
concentrations used were 1.2, 1.6 and 2 % Maxilact. (Where ▲: Lac, ▬: Glc, ٭: Gal, 
and ●: GOS) 
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Figures 3.11, 3.12, 3.13 and 3.14 showed how the initial substrate 
concentration influences both the transglycosylation and hydrolysis reactions. The 
synthesis of GOS is increased probably due to the decrease of the water activity in the 
media. The water activity of the assays with 350 g/l is 0.968, while the one of the 
assays with 200 g/l is 0.984. The influence of initial lactose concentration on β-
galactosidase activity is consistent with similar works in literature (Goulas et al., 
2007; Maugard et al., 2003).  
By comparing assays with different Whey Permeate concentration, at low 
enzyme concentration, i.e. 0.1% (Figure 3.11), it is possible to observe that GOS 
synthesis has a increasing trend throughout the reaction time. Furthermore, the 
maximum GOS achieved at the end of the reaction is almost doubled by increasing 
the starting lactose concentration (Figure 3.13). By increasing enzyme concentration, 
i.e. 0.4%, in the assay with 350 g/l, as an increase in GOS synthesis is observed 
(Figure 3.13). In the assay with 200 g/l GOS starting with 0.4% of enzyme (Figure 
3.11), GOS reached a maximum and then declined. At 0.8 and 1.2% enzyme 
concentrations and 350 g/l WP (Figures 3.13-3.14), GOS synthesis starts to decrease 
slowly after 4 hours of reaction, while at 1.6 and 2% (Figure 3.14) it decrease after 2 
hours. The different trends in GOS synthesis/degradation between the assays with 200 
and 350 g/l at the same enzyme concentration may be due to the higher lactose 
available as acceptor for the transglycosylation reaction with 350 g/l Whey Permeate.  
The trend of GOS synthesis in the assays with 200 g/l Whey Permeate 
(Figures 3.11-3.12) is consistent with the results obtained using the TLC assay (Figure 
3.5), although the HPLC method shows a lower quantity of GOS production.  
The GOS yield, as a percentage of all the sugars present in the media 
(GOS%TOT) (Dumortier et al., 1994) (Formula 3.13), has been calculated as the value 
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(%) of the GOS present at a certain time of the reaction (GOStx) divided by the sum of 
all the other species presents in the media at the same time (Lactx, Glctx and Galtx).  
 
                                                                                                                    (3.13) 
 
The degree of lactose conversion (DC) has been defined as a conversion of 
lactose to GOS and monosaccharides in percentage (Chockchausawasdee et al., 
2004). It has been calculated as the initial quantity of lactose (Lac0) minus the lactose 
present in the solution at a certain time (Lactx) divided by the initial lactose (Formula 
3.14).                                                                                                                               
                                                                                                                    (3.14) 
 
In Figure 3.15 the influence of enzyme concentration and Whey Permeate 
concentration is related to the GOS % of total sugars and lactose conversion (%). In 
the assay with 200 g/l of Whey Permeate, the maximum GOS synthesis (18%) is 
achieved when 62% of lactose is converted with 0.4% of Maxilact used. By increasing 
substrate concentration to 350 g/l of Whey Permeate, the maximum synthesised GOS 
increases to 24%, when 65% of lactose is converted with 0.8% of Maxilact. In both of 
the assays, by increasing of the enzyme concentration a higher percentage of lactose is 
converted but a smaller GOS percentage obtained. This may be due to a shift of the 
equilibrium of β-galactosidase reaction towards hydrolysis rather then 
transglycosylation (Figure 1.6). 
%
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Figure 3.15: Comparison of the effect of enzyme concentration on GOS % of 
total sugars at different Whey Permeate concentrations (200 -a- and 350 -b- g/l). 
Where: E: enzyme; ■: E 0.1; ■: E 0.4; ■: E 0.8; ■: E 1.2; ■: E 1.6; and ■: E 2%. 
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3.4 Model reduction of the GOS synthesis mechanism  
3.4.1 Reduced reaction mechanism model 
Previous studies (Iwasaki et al., 1996 and Kim et al., 2004) have investigated 
the modelling of GOS formation using the full feature mechanism model of reaction. 
Generally, this has resulted in an ill-conditioned system, where strong correlation 
between parameters and variables has resulted in no statistically meaningful results. 
The main approach to avoid this obstacle in this study focused on simplifying the 
reaction mechanism and tried to explain GOS synthesis with a reduced set of reaction 
steps (Boon et al., 1999 and 2000; Zhou et al., 2003; Neri et al., 2009). 
In this work, the GOS synthesis mechanism has been simplified on the basis of 
the following considerations based on previous studies by Boon et al., (1999 and 
2000) and Zhou et al., (2003): 
- Enzymatic hydrolysis is assumed to be rapidly equilibrated, lumping 
therefore the whole enzymatic hydrolysis mechanism into a single first 
order step. 
- There is no GOS synthesis inhibition process due to re-arrangement of 
the E:Gal complex with glucose by reaction of the E:Gal complex with 
glucose, to form allolactose. Therefore the step of allolactose formation 
is considered of negligible influence. 
From these hypotheses the following system of ordinary differential equations 
(ODE) was constructed (equations 3.15-3.17) (this model will be further referred in 
the following discussion as the reduced model): 
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E + Lac          E:Gal + Glc                                                                           (3.15)           
 
 
E:Gal                              E + Gal                                                                                (3.16) 
 
 
E:Gal + Lac                                               E + GOS                                                               (3.17) 
 
The material mass balances are described by the following equations (3.18-3.23):                                      
  
                                                                                                                    (3.18) 
                                                                     
 
                                                                                                                    (3.19)                               
                                                                                                                             
                                                                                                                    (3.20) 
 
                                                                          (3.21) 
  
                                                                                                                    (3.22) 
 
                                           (3.23) 
 
The kinetic parameters k1, kr3, k5 and kr5 are expressed in M-1min-1 and k3 is 
expressed in min-1. 
In this reduced model, lactose can react with the galactosyl-enzyme complex 
and the synthesis of galactooligosaccharides is assumed to be reversible. Lactose 
inhibition, allolactose production (Huber et al., 1976), mutarotation of galactose 
k1⎯⎯⎯→
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rk 3
← ⎯
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r ⋅⋅−⋅= 33 :
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(Bakken et al., 1992), separate production of tri- and tetrasaccharides (Iwasaki et al., 
1996), diffusional limitation and enzyme inactivation with time were not considered 
in the model. Also, temperature and pH effects on lactose hydrolysis and 
oligosaccharides synthesis were not included (Neri et al., 2009). 
 
3.4.2 Comparison of full model and reduced model set 
The kinetics of a general experiment for GOS synthesis (0.1% Maxilact 
concentration 200g/l of WP) together with the full model prediction are shown in 
Figure 3.16.  
Although the full model fitted well the HPLC data (Figure 3.16), the 
parameters were correlated highly with large standard errors (data not shown). This 
precluded from obtaining sound estimates of reaction rate constants that might be 
used to predict GOS synthesis under other conditions. 
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Figure 3.16: Measurement and model prediction with full model. HPLC assays 
with 0.1% Maxilact in WP (200 g/l) are shown. Symbols are the points of 
experimental data and lines are the curve fits of the species for the proposed model. 
Where ○: Lactose; ∆: Glucose; : Galactose and □: GOS. Assay conditions described 
in Materials and Methods (Section 2.4). 
 
In Table 3.3 the comparison of the residual sum of the squares between the full 
model and the reduced model is shown. It is possible to notice that the reduced model 
explained the data at least as well as the full model, with a minor increase in deviance 
and a considerable decrease in the correlation between parameters (no parameters 
with a correlation higher than 0.95 were found). This indicates that the reduced model 
could properly explain the GOS synthesis reaction, even with the elimination of four 
kinetic parameters from the nine parameters of the full model. 
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Table 3.3: Residual sum of squares of the weighted residuals (RSM) comparison 
between the full model -a-  and the reduced model -b- of the enzymatic assays with 
Maxilact (0.1, 0.4, 0.8, 1.2, 1.6 and 2%) and Whey Permeate (200 and 350 g/l).  
Substrate concentration 200 g/l Whey Permeate 
Enzyme concentration 0.1%E            0.4%E           0.8%E          1.2%E    1.6%E            2%E              
Full Model RSM 0.197 0.309 0.189 0.205 0.287 0.344 
Substrate concentration 350 g/l Whey Permeate 
Enzyme concentration 0.1%E            0.4%E           0.8%E          1.2%E    1.6%E            2%E              
Full Model RSM 0.569 0.808 0.713 0.1135 0.941 0.958 
 
Substrate concentration 200 g/l Whey Permeate 
Enzyme concentration 0.1%E            0.4%E           0.8%E          1.2%E    1.6%E            2%E              
Reduced Model RSM  0.196 0.302 0.178 0.194 0.256 0.313 
Substrate concentration 350 g/l Whey Permeate 
Enzyme concentration 0.1%E            0.4%E           0.8%E          1.2%E    1.6%E            2%E              
Reduced Model RSM  0.567 0.767 0.710 0.1135 0.935 0.957 
  
 
3.4.3 Fitting of enzymatic assay data with Maxilact and Whey Permeate as 
single experiments  
Figures 3.16-3.21 show the enzymatic assays carried out with different 
Maxilact concentrations (0.1, 0.4, 0.8, 1.2, 1.6, 2%) and/or Whey Permeate (200 and 
350 g/l) fitted as individual experiments using the JSim simulation program. From 
Figures 3.17-3.22 it is possible to observe that the proposed model explained not only 
the lactose hydrolysis, glucose and galactose release but also galactooligosaccharides 
synthesis by Kluyveromyces lactis β-galactosidase at various concentrations of 
enzyme and substrate. By comparison of the assays with different Whey Permeate 
concentration, it is clear that the fitting equations of the model for the assays with 350 
g/l of Whey Permeate (Figures 3.20-3.22) show a tendency to underestimate the 
glucose concentration. Similar results were found by Boon et al., (1999).  
Previously, GOS formation was observed for 5 hours by Iwasaki et al., (1996); 
for 12 hours by Neri et al., (2009); for 3.3 and 6.7 hours by Boon et al., (respectively 
1999 and 2000); and for 5 hours Kim et al., (2004). The extent of reaction time 
(a) 
(b) 
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studied in this work of 5 hours is therefore within the context investigated previously 
from other authors and it was not considered worthwhile to study the reactions further 
since GOS reach a maximum and then started to be degraded (Figures 3.11-3.14).  
Another parameter that changes within previous works in literature is the 
range of lactose concentrations studied. The reaction kinetics parameters were studied 
at different initial lactose concentration: 
- From 0.39 to 1.67M by Iwasaki et al., (1996) 
- 0.15, 0.28 and 0.88M by Kim et al., (2004); 
- From 0.19 to 0.59 mol/kg (ca 0.19 to 0.59M) by Boon et al., (1999); 
- Between 0.14 to 1.45M by Neri et al., (2009);  
This study covered a wide range of Whey Permeate concentrations, whose 
initial lactose content is included between 0.58M and 1.012M. The levels considered, 
described the whole reaction up to completion and exhaustion of all lactose in most of 
the experiments (Figures 3.17-3.22). However, lactose was not fully depleted in the 
assay with 0.1% of Maxilact and 350 g/l of Whey Permeate (Figure 3.20). This is may 
be due to diffusional restrictions arising from the viscosity of the system and the small 
concentration of enzyme used, both of which delayed GOS formation. Furthermore, 
the previously cited works in the literature have covered different lactose 
concentrations (Iwasaki et al., 1996; Kim et al., 2004; Boon et al., 1999; Neri et al., 
2009), whereas in the present study, different enzyme concentrations at two levels of 
Whey Permeate concentrations have been examined.  
Due to the variety of the initial lactose concentrations, quantity enzyme used 
and assay conditions by other authors, the maximum GOS achieved in the synthesis 
reaction shifts from 0.1 mol/kg (Boon et al., 1999 and 2000) to 0.51M (Neri et al., 
2009) and 0.05M (Kim et al., 2004). In this work, the maximum yield of 0.47M 
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(Results, section 3.2.1) was achieved and modelled using the equations proposed 
(equations 3.15-3.17).  
The results obtained fall within similar conditions to previous investigations of 
the GOS synthesis studies carried out. However, differences in the nature of substrate 
(Whey Permeate rather then pure lactose), concentration levels of substrate and 
enzyme tested and assays conditions could influence the obtained results. 
The effect of increasing WP concentration did result in slightly higher GOS 
maximum concentrations, with comparable reaction times. Normally higher enzyme 
concentrations would result in a shorter time to reach the maximum GOS 
concentration, with reaction times of around 50-60 minutes required to reach this 
maximum at the higher enzyme concentrations tested. 
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Figure 3.17: Experimental measurement of GOS synthesis and prediction of the 
individual fitting using the reduced reaction mechanism model. HPLC assays with 
0.1 and 0.4% Maxilact in WP (200 g/l) are shown. Points represent experimental data, 
where ○: Lactose; ∆: Glucose; :  Galactose and □: GOS, and lines the individual fit. 
Assay conditions are described in Materials and Methods (Section 2.4). 
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Figure 3.18: Experimental measurements of GOS synthesis and prediction of the 
individual fitting using the reduced reaction mechanism model. HPLC assays with 
0.8 and 1.2% Maxilact in WP (200 g/l) are shown. Points represent experimental data, 
where ○: Lactose; ∆: Glucose; :  Galactose and □: GOS, and lines the individual fit. 
Assay conditions are described in Materials and Methods (Section 2.4). 
________________________________________________________Chapter 3: Results 
 91
 
 
Figure 3.19: Experimental measurements of GOS synthesis and prediction of the 
individual fitting using the reduced reaction mechanism model. HPLC assays with 
1.6 and 2% Maxilact in WP (200 g/l) are shown. Points represent experimental data, 
where ○: Lactose; ∆: Glucose; :  Galactose and □: GOS, and lines the individual fit. 
Assay conditions are described in Materials and Methods (Section 2.4). 
________________________________________________________Chapter 3: Results 
 92
 
 
Figure 3.20: Experimental measurements of GOS synthesis and prediction of the 
individual fitting using the reduced reaction mechanism model. HPLC assays with 
0.1 and 0.4% Maxilact in WP (350 g/l) are shown. Points represent experimental data, 
where ○: Lactose; ∆: Glucose; :  Galactose and □: GOS, and lines the individual fit. 
Assay conditions are described in Materials and Methods (Section 2.4). 
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Figure 3.21: Experimental measurements of GOS synthesis and prediction of the 
individual fitting using the reduced reaction mechanism model. HPLC assays with 
0.8 and 1.2% Maxilact in WP (350 g/l) are shown. Points represent experimental data, 
where ○: Lactose; ∆: Glucose; :  Galactose and □: GOS, and lines the individual fit. 
Assay conditions are described in Materials and Methods (Section 2.4). 
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Figure 3.22: Experimental measurements of GOS synthesis and prediction of the 
individual fitting using the reduced reaction mechanism model. HPLC assays with 
1.6 and 2% Maxilact in WP (350 g/l) are shown. Points represent experimental data, 
where ○: Lactose; ∆: Glucose; :  Galactose and □: GOS, and lines the individual fit. 
Assay conditions are described in Materials and Methods (Section 2.4). 
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It can be seen in Figures 3.17 to 3.22 that the individual fitting of the model to 
the observed kinetics was good. However, it was noticed a poor prediction of the 
model for glucose kinetics was noticeable, especially at higher initial whey permeate 
concentrations. This may be due to experimental errors in the estimation of glucose 
due to HPLC peak overlapping and to the limitations of the model used, which ignore 
any further involvement of glucose in the reaction mechanism. Possible further 
improvements of the model and the analytical procedure should consider this, 
possibly improving the separation ability of the HPLC assay by the change of mobile 
phase. 
The kinetic parameters of the reduced model were estimated by using 
triplicated data for the enzymatic assays with different concentration of Whey 
Permeate (200 and 350 g/l) and Maxilact (0.1, 0.4, 0.8, 1.2, 1.6 and 2%). 
By definition, the parameters estimated should be positive since they are 
reaction constants in the given direction. Therefore the logarithms of the constants 
were estimated by fitting the time-course of lactose conversion data to the proposed 
reduced model with JSim (Materials and Methods, section 2.6) (Table 3.4). All the 
fitted parameters found were significant. 
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Table 3.4: Fitted parameter values of the enzymatic assays with Maxilact (0.1, 0.4, 
0.8, 1.2, 1.6 and 2%) and Whey Permeate (200 -a- and 350 -b- g/l). All figures are 
mean ± standard deviations. 
 
 
 
Figure 3.23 shows a schematic diagram of the reduced mechanism of GOS 
synthesis. 
 
 
 
 
 
 
Figure 3.23: Schematic representation of reduced model GOS synthesis mechanism. 
 
According to the reduced model mechanism of reaction (equations 3.15-3.17, 
Figure 3.23) the four rate constants can be described as follows: 
Parameters   
(log value) 
0.1%E      
200 g/l WP 
0.4%E            
200 g/l WP 
0.8%E           
200 g/l WP 
1.2%E          
200 g/l WP 
1.6%E            
200 g/l WP 
2%E              
200 g/l WP 
ln(k1) (M-1min-1) 4.3±0.7 10.3±1.1 8.4±0.5 7.9±0.8 18.3±1.5 8.2±1.8 
ln(k3) (min-1) 8.2±1.2 26.0±0.7 10.2±0.4 7.4±0.7 8.3±1.2 7.1±1.4 
ln(kr3) ( M-1min-1) 12.8±0.7 37.7±0.6 19.6±0.2 16.3±0.2 27.5±0.3 16.4±0.4 
ln(k5) (M-1min-1) 1.7±0.9 6±3 28.8±0.7 6.9±1.2 26.7±1.2 11.6±1.5 
ln(kr5) (M-1min-1) 6.5±1.7 18±4 37.9±0.9 15.6±1.2 45.3±1.8 20±2 
Parameters   
(log value) 
0.1%E           
350 g/l WP 
0.4%E            
350 g/l WP 
0.8%E            
350 g/l WP 
1.2%E          
350 g/l WP 
1.6%E            
350 g/l WP 
2%E               
350 g/l WP 
ln(k1) (M-1min-1) 1.6±0.6 1.2±0.2 7.3±1.9 10.4±1.9 11.3±1.7 6.1±1.8 
ln(k3) (min-1) 8.2±4  6±2 2.9±1.4 7.1±1.3 10.7±1.3 6.1±1.5 
ln(kr3) ( M-1min-1) 10.5±6 7±2 11.2±0.6 18.5±1.0 23±0.8 13.3±0.5 
ln(k5) (M-1min-1) 2.5±1.4 2.6±0.5 2.5±0.9 5.2±0.1 8±4 7±4 
ln(kr5) (M-1min-1) 3.9±1.4 2.1±1.1 8.8±0.9 17±9 21±5 14±5 
a
Lac 
E
Glc
k1
E:Gal 
LacE
GOS 
E
kr3kr5 
k3k5 
 
H2O 
Gal 
b 
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- k1 defines the Enzyme:Galactose complex production, which is the 
precursor of GOS. The higher this value is, the faster the GOS 
formation proceeds; 
- k3 and kr3 are a measure of hydrolysis of the Enzyme:Galactose 
complex. The higher the ratio k3/kr3 is, the more inhibition of GOS 
formation will occur; 
- k5 and kr5 express the formation of GOS from the Enzyme:Galactose 
complex. The higher the ratio k5/kr5 is, the faster GOS are synthesized. 
 
In Figure 3.24 the estimated ln(k1) for all experiments are compared. As can 
be seen, in general, experiments at 200g/l show a higher rate of conversion from 
lactose to E:Gal complex, indicating that it will take longer for the E:Gal complex to 
reach critical concentrations for GOS formation in the 350g/l experiments. 
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Figure 3.24: Comparison of estimated ln(k1) kinetic parameter for different 
initial enzyme and Whey Permeate concentrations. Assay conditions described in 
Materials and Methods (Section 2.4). Error bars show the 95% CI for the estimated 
parameters from individual experiments.  
 
In Figure 3.25 the ratio of the inhibitory step of GOS synthesis reaction is 
plotted for the different experiments performed. It can be seen that inhibition becomes 
more important at the lower Whey Permeate concentrations only when intermediate 
enzyme concentrations are used. Otherwise, the higher the concentration of Whey 
Permeate used, the faster the inhibition of GOS synthesis occurs. 
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Figure 3.25: Comparison of estimated inhibition kinetics parameters 
ln(k3)/ln(kr3) for different initial enzyme and Whey Permeate concentrations. 
Assays conditions described in Materials and Methods (Section 2.4). Error bars show 
the 95% CI for the estimated parameters from individual experiments. 
 
In Figure 3.26 the ratio of the GOS formation kinetic parameters is plotted for 
the different assays considered. Generally, the assay with the smallest concentration 
of Whey Permeate (200 g/l) has the higher ratio ln(k5)/ln(kr5), which indicates that the 
GOS synthesis reaction is happening faster than at higher concentrated Whey 
Permeate solutions (350 g/l). This is may be due to the increasing viscosity of the 
media that results from increasing the concentration of substrate. 
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Figure 3.26: Comparison of estimated GOS formation kinetics parameters 
ln(k5)/ln(kr5) for different initial enzyme and Whey Permeate concentrations. 
Assays conditions described in Materials and Methods (Section 2.4). Error bars show 
the 95% CI for the estimated parameters from individual experiments. 
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3.4.4 Global fitting of enzymatic assays with Maxilact and Whey Permeate  
3.4.4.1 Preliminary screening of data 
After observing that the estimated parameters from individually fitted 
experiments, the whole set of data for 200g/l (and then 350g/l) was considered for 
modelling with a single set of parameter estimates. This will allow us to describe the 
mechanism of reaction as a whole and to obtain more precise information about the 
reaction parameters. 
As a preliminary screening of data to obtain an estimate of a single set of 
parameters that would explain all the GOS synthesis performed at the same WP 
concentration was carried out. The average glucose (Glc) and galactose (Gal) residue 
ratio was calculated for all experiments, based on the sugar residue balance, as 
previously shown from Boon et al., 1999: 
                                                                                                                                 
                                                                                                                                (3.23) 
                                                                                                                                                                        
The model used only lactose as substrate; as a consequence the ratio should be 
close to 1. An error of 10% was accepted; therefore all experimental data for which 
the average ratio was lower than 0.9 or higher than 1.1 the data from the peak with 
less confidence, glucose, were removed from the fitting data set.  
 
3.4.4.2 Global fitting of the enzymatic assays with different Whey Permeate 
concentrations and Maxilact concentrations 
All the enzymatic assays carried out with different Whey Permeate and 
Maxilact concentrations levels were modelled in one single fit using the reduced 
model previously described (Results, section 3.5.2). For that, the ODEPACK Fortran 
[ ]
[ ]
[ ] [ ] [ ]
[ ] [ ] [ ]GOSGalLac
GOSGlcLac
Gal
Glc
residue
residue
⋅++
++=
2
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library for simulation purposes and the ODRPACK Fortran library for fitting (see 
Materials and Methods, section 2.6) were used. This produced one set of parameters, 
which together with the proposed ODE set of equations would be able to describe all 
the kinetics of GOS formation. 
Global fittings using firstly all data available at 200g/l, secondly all data 
available at 350g/l and finally using both sets of data together were carried out. The 
multiresponse nonlinear regression procedure converged to a single set of parameters 
for the 350g/l and for the global set of data. However, the 200g/l data set regression 
was found not to converge. Several attempts were made with different initial 
estimates, however no adequate final parameter estimate set was found.  
In Figures 3.27-3.30 the global modelling of the assays with 200 and 350 g/l at 
increasing Maxilact concentrations are shown. The global fitting to the experimental 
data is good for both initial Whey Permeate concentrations employed. The model 
always describes accurately GOS synthesis and, in most of the cases, the lactose 
depletion and the galactose/glucose release. Because of the data deletion of glucose 
(Section 3.5.1) using the glucose/galactose ratio, there is a significant amount of 
experiments where the glucose seems to be underestimated, especially when using 
350g/l of initial WP. This is not considered a problem of the model, rather a practical 
solution to the imbalance observed experimentally in the stoichiometric ratios of 
compounds during the reaction.   
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Figure 3.27: Experimental measurements of GOS synthesis and prediction of the 
global fitting using the reduced reaction mechanism model. HPLC assays with 0.1, 
0.4 and 0.8% Maxilact in WP (200 g/l) are shown. Points represent experimental data, 
where ♦: Lactose; ▲: Glucose; ●:  Galactose and ■: GOS, and lines the global fit. 
Assay conditions are described in Materials and Methods (Section 2.4). 
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Figure 3.28: Experimental measurements of GOS synthesis and prediction of the 
global fitting using the reduced reaction mechanism model. HPLC assays with 1.2, 
1.6 and 2% Maxilact in WP (200 g/l) are shown. Points represent experimental data, 
where ♦: Lactose; ▲: Glucose; ●:  Galactose and ■: GOS, and lines the global fit. 
Assay conditions are described in Materials and Methods (Section 2.4). 
________________________________________________________Chapter 3: Results 
 105
0.1%E 350g/L WP
0.00
0.20
0.40
0.60
0.80
1.00
0 30 60 90 120 150 180 210 240 270 300
Time [min]
C
on
ce
nt
ra
tio
n 
[M
]
        
0.4%E 350g/L WP
0.00
0.20
0.40
0.60
0.80
1.00
0 30 60 90 120 150 180 210 240 270 300
Time [min]
C
on
ce
nt
ra
tio
n 
[M
]
 
0.8%E 350g/L WP
0.00
0.20
0.40
0.60
0.80
1.00
0 30 60 90 120 150 180 210 240 270 300
Time [min]
C
on
ce
nt
ra
tio
n 
[M
]
  
Figure 3.29: Experimental measurements of GOS synthesis and prediction of the 
global fitting using the reduced reaction mechanism model. HPLC assays with 0.1, 
0.4 and 0.8% Maxilact in WP (350 g/l) are shown. Points represent experimental data, 
where ♦: Lactose; ▲: Glucose; ●:  Galactose and ■: GOS, and lines the global fit. 
Assay conditions are described in Materials and Methods (Section 2.4). 
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Figure 3.30: Experimental measurements of GOS synthesis and prediction of the 
global fitting using the reduced reaction mechanism model. HPLC assays with 1.2, 
1.6 and 2% Maxilact in WP (350 g/l) are shown. Points represent experimental data, 
where ♦: Lactose; ▲: Glucose; ●:  Galactose and ■: GOS, and lines the global fit. 
Assay conditions are described in Materials and Methods (Section 2.4). 
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The fitting kinetics parameter values of the global fitting of the assays with 200 g/l 
and 350 g/l are shown in Table 3.5. 
 
Table 3.5: Global fitted parameter estimates of the enzymatic assays with different 
Whey Permeate (200 g/l and 350 g/l) and Maxilact concentrations (0.1, 0.4, 0.8, 1.2, 
1.6 and 2%). No convergence was observed for the data at 200g/l. All figures are 
estimate ± standard error. 
Parameters     
(log value) 
350g/l WP 200 & 350g/l WP 
ln(k1) (M-1min-1) 5.84±0.06 7.89±0.05 
ln(k3) (min-1) 1.1±0.3 4±6 
ln(kr3) (M-1min-1) 8.3±0.3 13±6 
ln(k5) (M-1min-1) 1.37±0.9 0.8±0.6 
ln(kr5) (M-1min-1) 8.92±1.0 10.2±0.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
________________________________________________________Chapter 3: Results 
 108
3.5 Use of solvents in the GOS synthesis reaction 
The presence of solvents has been reported to alter the specificity of a number of 
enzymes. Thus, we examined the influence of addition of low amounts of solvents to 
the GOS synthesis reaction. While some solvents caused partial enzyme inactivation 
others did not markedly affect enzyme activity.  
The solvents used were ethanol (EtOH), acetonitrile (ACN), dioxane, diethyl 
ether, and acetone. 
The solvents also lower water activity which may favour GOS synthesis. 
However, the solvents influenced only slightly the water activity of the media (Table 
3.6); probably due to the small amount added. 
 
Table 3.6: Influence of different solvents (acetonitrile, ethanol, diethyl ether, dioxane, 
and acetone) at the same concentration (10%) in Whey Permeate (200 g/l) on water 
activity (aw) in comparison to the control. All figures are mean ± standard deviations. 
aw WP Control  aw WP + 
ACN  
aw WP  + 
EtOH  
aw WP +  
diethyl ether  
aw WP + 
dioxane 
aw WP + 
acetone 
0.988±0.001 0.987±0.001 0.987±0.001 0.983±0.001 0.987±0.001 0.985±0.001 
 
It was noticed that some solvents, such as acetonitrile and dioxane, inhibited β-
galactosidase activity. Some other solvents, such as acetone and diethyl ether, 
permitted β-galactosidase reaction. However, the yield of GOS synthesized in 
comparison to the control was not affected (Figure 3.31).  
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Figure 3.31: GOS synthesis in presence of different solvents. Average values of 
three replicates are reported with relative error bars. Assays were carried out in 
phosphate buffer (0.1 M, pH 6.8) with Whey Permeate (200 g/l), solvent (10%) and 
0.4% Maxilact, at 40ºC, for 300 minutes reaction. Solvent added were: acetone, 
acetonitrile, diethyl ether, dioxane and ethanol. (Where ▲: Lac, ▬: Glc, ٭: Gal, and 
●: GOS). 
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3.5.1 Fitting of the enzymatic assays carried out with solvents addition  
Figures 3.32-3.37 shows the kinetic parameters of the enzymatic assays 
carried out with the addition of solvents (10%) in the reaction mixture, composed of 
Whey Permeate (200 g/l) and Maxilact (0.4%) fitted as single experiments with the 
JSim simulation program. The solvents used were ethanol, acetonitrile, acetone, 
diethyl ether and dioxane (see Results, section 3.2.2).  
Figure 3.31 shows the changing of ln(k1) between the assays carried out with 
solvents.  All the solvents, within experimental error, allowed for the formation of 
E:Gal complex at the same rate. E:Gal is the precursor to GOS formation. However 
acetonitrile and dioxane had slower kinetics, which is consistent with the initial 
lactose depletion observed in these assays (Figure 3.31). In Figure 3.32 it can be seen 
that the introduction of small concentrations of acetonitrile and dioxane affected 
significantly (p<0.05) the initial step of precursor formation in the reaction.  
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Figure 3.32: Comparison of estimated GOS formation kinetics parameters ln(k1) 
for enzymatic assays carried out with the addition of solvents. Assay conditions 
described in Materials and Methods (Section 2.4.1). Error bars show the 95% CI for 
the estimated parameters from individual experiments. 
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The comparison of the kinetic parameter ln(k3) and ln(kr3) between the 
different solvents can be seen in Figures 3.33 and 3.34. The use of organic solvents 
resulted generally in a reduction of both ln(k3) and ln(kr3) compared to the control. 
This is expected to result in slower degradation of the E:Gal complex towards the 
formation of free Galactose. This might have the interesting result of displacing the 
reaction towards the formation of GOS, which is characterised by ln(k5) and ln(kr5). 
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Figure 3.33: Comparison of estimated GOS formation kinetics parameters ln(k3) 
for enzymatic assays carried out with the addition of solvents. Assay conditions 
described in Materials and Methods (Section 2.4.1). Error bars show the 95% CI for 
the estimated parameters from individual experiments. 
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Figure 3.34: Comparison of estimated GOS formation kinetics parameters 
ln(kr3) for enzymatic assays carried out with the addition of solvents. Assay 
conditions described in Materials and Methods (Section 2.4.1). Error bars show the 
95% CI for the estimated parameters from individual experiments. 
 
The ratio between ln(k3)/ln(kr3) (Figure 3.35) shows that the use of dioxane 
and diethyl ether reduced this ratio (p<0.05). Therefore the use of solvents had an 
observable effect in the balance of the reaction mechanism. 
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Figure 3.35: Comparison of estimated inhibition kinetics parameters 
ln(k3)/ln(kr3) for enzymatic assays carried out with the addition of solvents. Assay 
conditions described in Materials and Methods (Section 2.4.1). Error bars show the 
propagated 95% CI for the estimated parameters from individual experiments. 
 
The kinetic parameter ln(k5) (Figure 3.36) did not change between the 
experiments taken into consideration. No statistically significant difference between 
the different solvents was found. 
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Figure 3.36: Comparison of estimated GOS formation kinetics parameters ln(k5) 
for enzymatic assays carried out with the addition of solvents. Assay conditions 
described in Materials and Methods (Section 2.4.1). Error bars show the 95% CI for 
the estimated parameters from individual experiments. 
 
In Figure 3.37 the kinetic parameter ln(kr5) is represented. The assay carried 
out with dioxane addition showed a higher value then the other assays (p<0.05). 
Hence, in the presence of this solvent, the transglycosylation reaction is shifted 
towards the degradation of GOS rather then its synthesis. This is consistent with the 
kinetics shown in Figure 3.30. 
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Figure 3.37: Comparison of estimated GOS formation kinetics parameters ln(kr5) 
for enzymatic assays carried out with the addition of solvents. Assay conditions 
described in Materials and Methods (Section 2.4.1). Error bars show the 95% CI for 
the estimated parameters from individual experiments. 
 
The ratio between ln(k5)/ln(kr5) (Figure 3.38) showed that the assays carried 
out with acetone, diethyl ether and ethanol had the same GOS formation mechanism 
as the control.  
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Figure 3.38: Comparison of estimated GOS formation kinetics parameters 
ln(k5)/ln(kr5) for enzymatic assays carried out with the addition of solvents. 
Assays conditions described in Materials and Methods (Section 2.4.1). Error bars 
show the propagated 95% CI for the estimated parameters from individual 
experiments. 
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3.6 Enzyme comparison 
Many authors have sought to improve GOS synthesis by the selection of 
enzymes that are more efficient than others previously studied. It is generally believed 
that yeast enzymes are more suited for industrial processes than bacterial ones 
(Rustom et al., 1998; Cheng et al., 2006).  However, a central problem with the data 
from the literature is that it is difficult to decide whether one enzyme source is better 
than another for GOS synthesis. This is due to the fact that different researchers have 
used different assay conditions such as temperature, pH, substrate concentration and 
enzyme concentration. 
Many researchers have claimed that one enzyme preparation is better than 
another but have not used a standard that allows easy comparison between 
researchers. Where comparisons have been made between enzymes interpretation has 
been difficult since the enzymes were estimated at different pH, temperature, 
inclusion level –all factors that affect GOS synthesis. 
We have explored this issue by attempting to compare two enzymes from 
widely different organism: Kluyveromyces lactis and Esherichia coli: one is 
eukaryotic, the other prokaryotic. 
The DNA sequences are compared through a Basic Logical Alignment Search 
Tour (BLAST) search carried out via the ClustalW website. The β-galactosidases 
sequences were taken from BRENDA-enzymes database (Chang et al., 2009). As the 
Escherichia coli strain used in the Sigma Aldrich preparation is unknown, a consensus 
sequence was deduced via the ClustalW website. The alignment file was then plotted 
in GENEDOC© (2000) in order to show sequences identities through shading utilities 
(Figure 3.39). 
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Figure 3.39 Alignments sequences of Kluyveromyces lactis and Escherichia coli 
consensus sequence via ClustalW website. Shadows show identities between the 
sequences. 
 
                                                                                                    
                      *        20         *        40         *        60         *        80       
Kluyveromy : ------MSCLIPENLRNPKKVHEN-RLPTRAYYYDQD-------------IFESLNGPWAFALFDAPLDAPDAKNLDWET :   60
Escherichi : MTMITDSLAVVMNRWENIQLTHENHRLAPRAYFFSYDSAQARTFARETSSLFLPLSGQWNFHFFDHPLQVPEAFTSEALM :   80
                      66     N    HEN RL  RAY55  D             6F  L G W F  FD PL  P A              
                                                                                                    
                      *       100         *       120         *       140         *       160       
Kluyveromy : AKKWSTISVPSHWELQEDWKYGKPIYTNVQYPIPIDIPNPPTVNPTGVYARTFELDSKSIESFEHRLRFEGVDNCYELYV :  140
Escherichi : AD-WGHITVPAMWQMEG---HGKLQYTDEGFPFPIDVPFVPSDNPTGAYQRIFTLS----DGWQTLIKFDSVTYFEVYVY :  152
             A  W  I3VP  W262     GK  YT1  5P PID6P  P3 NPTG Y R F L       52  64F  V               
                                                                                                    
                      *       180         *       200         *       220         *       240       
Kluyveromy : NGQYVGFNKGSRNGAEFDIQKYVSEGENLVVVKVFKWSDSTYIEDQDQWWLSGIYRDVSLLKLPKKAHIEDVRVTTTFVD :  220
Escherichi : NGQYVGFSKGSR-LTAFDISAMUKTGDNLG-VRVMQWADSTYVED--QMWSAGIFRDVYLVGKMLTHINDFVRTD---FD :  225
             NGQYVGF KGSR    FDI      G NL  V4V  W DSTY6ED  Q W  GI5RDV L6          VR      D       
                                                                                                    
                      *       260         *       280         *       300         *       320       
Kluyveromy : SQYQDAELSVKVDVQGSSYDHINFTLYEPEDGSKVYDASSLLNEENGNTTFSTKEFISFSTKKNEETAFKINVKAPEHWT :  300
Escherichi : EAYCDATLSCEVVLENLAASPVVTTLY------------TLFGERVVHSSAIDHLAIEKRGGYLTSASFAFTVEQPQQWS :  293
               Y DA LS  V 62      6  TLY            3L  E    33      I           F   V  P2 W3       
                                                                                                    
                      *       340         *       360         *       380         *       400       
Kluyveromy : AENPTLYKYQLDLIGSDGS-VIQSIKHHVGFRQVELKDGNITVNGKDILFRGVNRHDHHPRFGRAVPLDFVVRDLILMKK :  379
Escherichi : AESPYLYHLVMTLKDANGNGVCEVVPQRVGFRDIKVRDGLFWINWRVVMLHGVNRHDNDHRKGRAVG-HRVEKDLQLMKQ :  372
             AE P LY   6 L   1G  V 2 6   VGFR 6 64DG   6N 4 66  GVNRHD   R GRAV    V 4DL LMK        
                                                                                                    
                      *       420         *       440         *       460         *       480       
Kluyveromy : FNINAVRNSHYPNHPKVYDLFDKLGFWVIDEADLETHGVQEPFNRHTNLEAEYPDTKNKLYDVNAHYLSDNPEYEVAYLD :  459
Escherichi : HNINSVRTAMYPNDPRFYELCDIYGLFVMAETDVESHGFANVG--------------------DISRITDDPQWEKVYVE :  432
              NIN VR   YPN P4 Y L D  G 5V6 E D6E3HG                         1   63D1P25E  Y6        
                                                                                                    
                      *       500         *       520         *       540         *       560       
Kluyveromy : RASQLVLRDVNHPSIIIWSLGNEACYGRNHKAMYKLIKQLDPTRLVHYEGD-LNALSADIFSFMYPTFEIMERWRKNHTD :  538
Escherichi : RIVRHIHAQKNHPSIIIWSLGWESGYGCNIRAMYHAAKALDDTRLVHYEEDGRADAEWDIISTMYTRVPLMNEFGEYPHP :  512
             R    6    NHPSIIIWSLG E  YG N 4AMY   K LD TRLVHYE D       DI S MY    6M  5             
                                                                                                    
                      *       580         *       600         *       620         *       640       
Kluyveromy : ENGKFE------KPLILCEYGHAMGNGPGSLKEYQ--ELFYKEKFYQGGFIWEWANHGIEFED------VSTADGKLHKA :  604
Escherichi : SIKKWLSLPGE-KPRIICEYAHAMGNGPGGLTEYQNVNVFYKHDCIQGHYVWEWCDHGIQAQDNVWYKFGGYGDDNGNVW :  591
                K5       KP I6CEY HAMGNGPG L EYQ   6FYK    QG 56WEW 1HGI2 2D          D             
                                                                                                    
                      *       660         *       680         *       700         *       720       
Kluyveromy : YAYGGDFKEEVHDGVFIMDGLCNSEHNPTPGLVEYKKVIEPVHIK---IAHGSVTITNKHDFITTDHLLFIDKDTGKTID :  681
Escherichi : YKFGG-YGDYPNNYNFCCDGLIYSDQTPGPGLKEYKQVUAPVKIHALDLTRGELKVENKLWFTTLDDYTHAEVRAEGETL :  670
             Y 5GG 5     1  F  DGL  S   P PGL EYK V  PV I    6  G 6 6 NK  F T D                     
                                                                                                    
                      *       740         *       760         *       780         *       800       
Kluyveromy : VPSLKPEESVTIPSDTTYVVAVLKDDAG-----------------VLKAGHEIAWGQAELPLKVPDFVTETAEKAAKIND :  744
Escherichi : ATQQIKIRDVAPNSEAPLQITLPQLDADRGEAFLNITVTKDSRTRYSEAGHSIATYQFPLKENTAQPVPFAPNNARPLTL :  750
                      V   S     6 6   DA                     AGH IA  Q  L       V      A  6         
                                                                                                    
                      *       820         *       840         *       860         *       880       
Kluyveromy : GKRYVSVESSGLHFILDK-LLGKIESLKVKGKEISSKFEGSSITFWRPPTNNDEPRDFKNWKKYN-----IDLMKQNIHG :  818
Escherichi : EDDRLSCTVRGYNFAITFSKSGKPTAWQVNGESLLTRE--PKINFFKNP-NIDNKQEYGLWQRNNAWVEHLQINQEHLRD :  827
                 6S    G  F 6     GK     V G  6 34     I F54 P N D    5  W 4 N     6 6  2 6         
                                                                                                    
                      *       900         *       920         *       940         *       960       
Kluyveromy : VSVEKGSNGSLAVVTVNSRISPVVFYYGFETVQKYTIFANKINLNTSMKLTGEYQ---PPDFPRVGYEFWLGDSYESFEW :  895
Escherichi : FAVEQSDDGEVLIISR-TVIAPPVFDFGGKTLMCTYIWR--IAADGVBALSGERYGDYPHIIPCIGFTMGINGEYD-QVY :  903
               VE   1G 6 663  3 I P VF 5G  T6    I5   I  1    L3GE     P   P 6G5   6   Y    5       
                                                                                                    
                      *       980         *      1000         *      1020         *      1040       
Kluyveromy : LGRGPGESYPDKKESQRFGLYDS-KDVEEFVYDYPQENGNHTDTHFLNIKFEGAGKLSIFQKEKPFNFKISDEYGVDEAA :  974
Escherichi : YGRGPGENYADSQQANIIDIWRSTVDAMFNEYPFPQNNGNRQHVRWTALTNRHGNGLLVVP-QRPINFSAWHGSEVLDSW :  982
              GRGPGE Y D  2     65 S  D     Y 5PQ NGN     5  6       L 6   24P NF       V           
                                                                       
                      *      1060         *      1080         *        
Kluyveromy : HACDVKRYGRHYLRLDHAIHGVGSEACGPAVLDQYRLKAQDFNFEFDLAFE : 1025
Escherichi : VWFRDFSYG-------FTLLPVSFFEATAQSLASYEFGAGFFSTNLHSEKQ : 1026
                    YG         6  V         L  Y   A  F        2       
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The two enzyme preparations were assayed for GOS synthesis at: 
- same pH (phosphate buffer 0.1 M, pH 7.0); 
- same substrate concentration (Whey Permeate at 200 g/l); 
- same temperature (37ºC); 
The enzyme preparation were normalised to the same activity as measured by 
initial rate of lactose consumption in the first hour of reaction.  
Under these conditions no significant difference in GOS synthesis profile was 
observed (Figure 3.40).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.40: Comparison assays with different enzyme sources added 
(Kluyveromyces lactis -a- and Escherichia coli -b-). Average values of three 
replicates are reported with relative error bars. Assays were carried out in phosphate 
buffer (0.1 M pH 7.0) with Whey Permeate (200 g/l) at 37ºC, for 300 minutes reaction 
time. (Where ▲: Lac, ▬: Glu, ٭: Gal, and ●: GOS). 
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3.6.1 Fitting of the enzymatic assays carried out with different sources of β-
galactosidase  
The enzymatic assays carried out with different sources of β-galactosidase at 
the same conditions (substrate concentration, pH, temperature, time, ionic strength) 
have been fitted as single experiments. In Figure 3.41 the comparison of the kinetic 
parameters of the enzymatic assays carried out with different sources of β-
galactosidase is shown. It can be seen that no parameters are different (p<0.05). 
Therefore, using different enzymes normalised to the same activity scale did not affect 
the maximum GOS formation, as was observed in the experimental results (Figure 
3.40). 
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Figure 3.41: Comparison of estimated GOS formation kinetics parameters ln(k1), 
ln(k3), ln(kr3), ln(k5) and ln(kr5) for different β-galactosidase sources at the same 
assay conditions. Error bars show the 95% CI for the estimated parameters from 
individual experiments. Assay conditions are described in Materials and Methods 
(Section 2.4.2) 
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Figure 3.42 shows the fitting of the enzymatic assays with the reduced model 
using the above kinetic parameters. From Figure 3.42 it is possible to see how the 
model fitted well the experimental data, especially for lactose degradation and GOS 
formation. 
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Figure 3.42: Experimental measurements of GOS synthesis and prediction of the 
global fitting using the reduced reaction mechanism model. HPLC assays with 
0.2% (vol/vol) Kluyveromyces lactis and 0.1 mg/ml Escherichia coli in WP (200 g/l) 
are shown. Points represent experimental data, where ○: Lactose; ∆: Glucose; :  
Galactose and □: GOS, and lines the best global fit. Assay conditions are described in 
Materials and Methods (Section 2.4.2). 
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3.7 Attempts to produce high GOS preparation 
Synthesis of GOS reaches a maximum for all enzymes when about 60% 
lactose conversion has occurred and subsequently declines (Figure 3.15). It was not 
possible to obtain GOS yield higher than 24% (w/w) for any combination of enzyme 
or WP concentration assayed (Figure 3.15 b). Preparations high in GOS are of great 
industrial interest due to the increasing interest in probiotic preparations for their 
functional properties (see introduction, section 1.4). After characterising the reaction 
mechanism in previous experimental work, an attempt was made to produce a 
carbohydrate fraction enriched in GOS by further processing the reaction mixture. 
The following experiments were carried out: 
1. Selective enrichment of the GOS mixture by lactose crystallisation. 
2. Increase of GOS yield by addition of WP during the reaction mixture. 
 
3.7.1 Lactose crystallization 
The first series of experiments attempted to selectively crystallise lactose from 
GOS synthesis reaction mixtures. An assay with 0.8% Maxilact and 350 g/l of Whey 
Permeate was chosen as the one that gave the highest GOS yield of the all 
experiments. At the maximum point of GOS synthesis (90 minutes), the reaction was 
quenched by immersing the reaction medium in boiling water.  The GOS synthesis 
reaction mixture was concentrated slowly using a Rotary evaporator. The objective of 
this step was to attempt to induce lactose to crystallise. When 50% of the water was 
removed, the solution was divided into 100 ml beakers and stored at 4 ºC and 25 ºC in 
order to allow lactose crystals to grow. Further water removal was difficult due to the 
formation of viscous syrup. A few seeds of lactose were added to stimulate crystal 
formation (Gänzle et al., 2008). The solutions were kept without agitation, until 
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further analysis, for three weeks. Contrary to what was expected, none of lactose or 
other sugars in the two solutions did crystallise. Prolonged evaporation was used 
concentrate the GOS synthesis reaction mixture. This caused the thickening of the 
syrup and no crystalline material was observed. The negligible lactose crystallization 
might have been due to presence of other sugars in the solutions and the high viscosity 
of the solution itself (Ibarz et al., 2002). At the moment, there are no studies regarding 
the effects of glucose, galactose and GOS, simultaneously, on lactose crystallization.  
A HPLC analysis of the concentrated solutions was carried out. The 
concentrated solutions presented a higher concentration of GOS, as well as the other 
species in solutions, i.e. lactose, glucose and galactose but the ratio of species was the 
same as for the control (Table 3.7).  
 
Table 3.7: Influence of water removal on GOS content. Where Lac: lactose; Glc: 
glucose; Gal: galactose. 
Sample GOS (g/l) Lac (g/l) Glc (g/l) Gal (g/l) GOS Yield 
0.8% E + 350 g/l WP 
(Control) 68.614 100.266 119.389 70.797 23.623 
0.8% E + 350 g/l WP After 
rotavapor stored at 4 ºC 93.152 184.716 211.550 93.152 19.033 
0.8% E + 350 g/l WP After 
rotavapor stored at 25 ºC 93.839 190.026 213.549 93.840 18.865 
 
From Table 3.7 it is possible to observe that the two different storage 
temperatures did not influence lactose crystallization.  
It was assumed that lactose crystallization in the analysed systems will 
eventually occur; however the time scale necessary to let lactose crystals form is not 
compatible with industrial application. Therefore other approaches to increase GOS 
yield were examined.  
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3.7.2 Addition of Whey Permeate 
The results obtained comparing assays with different Whey Permeate 
concentrations indicated that high concentrations of substrate enhanced GOS yield 
(Results, section 3.2.1). Therefore an attempt to add Whey Permeate to the synthesis 
mixture at the maximum point of GOS synthesis was made. The reaction mixture used 
for this study was 0.8% Maxilact and 350 g/l of Whey Permeate. A quantity of Whey 
Permeate solids was added to that synthesis mixture (70 g in 100 ml) after maximum 
GOS concentration was achieved (90 minutes) and stirred to facilitate its dissolution. 
It was not possible to dissolve all the Whey Permeate powder, due to the low 
solubility of lactose and the fact that it was not possible to bring the solution to its 
boiling point since this would have caused complete enzyme denaturation.  The 
reaction component profile of the sugar species for the assay with addition of Whey 
Permeate are presented in Figure 3.43. 
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Figure 3.43: WP addition at 90 minutes of the enzymatic assay. Assay was carried 
out in phosphate buffer (0.1 M, pH 6.8) with Whey Permeate (350 g/l) and 0.8% 
Maxilact, at 37 ºC, for 5 hours reaction time. After 90 minutes from the starting of the 
reaction Whey Permeate (70 g/100 ml) was added (arrow) (Where ▲: Lac, ▬: Glu, ٭: 
Gal, and ●: GOS). 
  
The Figure 3.43 shows that by adding more substrate to the reaction mixture at 
the point of maximum GOS synthesis initially induces an increase in GOS levels, 
which thereafter slowly decreases. The maximum GOS yield achieved was 22% 
(w/w) in comparison to the 24% (w/w) of the control. 
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4 Discussion 
The synthesis of galactooligosaccharide from lactose, using β-galactosidases, 
has been extensively investigated over the last 50 years due to the functional 
properties of GOS as prebiotics (Tanaka et al., 1983; Hidaka et al., 1986 and 1988; 
Kunz et al., 1993; Champ et al., 2003). The interest in GOS synthesis has increased 
since its inclusion in Japanese legislation regarding foods for specified health use 
(Farnworth, 1997).  
Many researchers have investigated the GOS synthesis reaction, with the 
objective of increasing the final GOS yield by changing β-galactosidases sources 
and/or synthesis conditions (Tables 1.5-1.10). However, most of the literature on GOS 
synthesis achieves a maximum GOS yield of 20-24% and only a few laboratories 
report yields higher than 40% (Tables 1.5-1.10). Variability in GOS yield may be 
influenced by several factors: 
• competition between hydrolysis and transglycosylation at the β-
galactosidase active site (Figures 1.4 and 1.6); 
• low lactose aqueous solubility (Hunziker et al., 1962); 
• the inhibitory effects of monosaccharides released during the reaction 
(Bakken et al., 1992; Shin et al., 1998); 
• the viscosity of concentrated lactose solutions that slow the reaction 
kinetics (Iwasaki et al., 1996).  
 
In the present work, optimisation of GOS synthesis was examined for 
application on an industrial scale.  A TLC and a HPLC assay method were used for 
analysing GOS synthesised by the enzymatic assays with β-galactosidases. A 
literature review showed that these analytical techniques are amongst the most widely 
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used in the field of GOS analysis, due to their short analysis time and the simple 
laboratory instrumentation required. This makes bench scale application and the study 
of reaction kinetics possible.  
 
4.1 Analysis of GOS synthesis by TLC assay method 
At the outset of these studies we attempted to devise a rapid, quantitative assay 
based on separation of GOS synthesis reactants and products by TLC. 
We showed this analytical method could be successfully used for quantitation 
of individual components. However, problems with the precision and accuracy of this 
analytical method were encountered: 
• The precision of analysis of some components (e.g. GOS and glucose) 
were better for others (i.e. galactose and lactose) as can be seen in 
Table 3.1. This may be due to differences between TLC plates that 
produce variations in separation and staining. 
• When comparing the results obtained with TLC analysis against 
similar results in the literature, it was observed that the TLC method 
produced a biased result, with overestimation of GOS production 
(Zhou et al., 2003; Kim et al., 2004). The lack of complete separation 
between GOS components and lactose may have caused this loss of 
accuracy.  
Attempts were made to improve TLC plate variation by taking into account 
the differences in background staining between plates by the inclusion of internal 
standards to correct for run to run variation. Attempts were also made to improve 
resolution of the TLC method by examining a wide variety of solvent systems to 
improve separation and by examining different spot visualisation methods. Despite 
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screening a number of different configurations of solvent systems and staining 
methods, significant problems in precision and accuracy remained. 
However, TLC allowed the analysis of more than thirty samples per day and 
therefore facilitated the screening of trends in the kinetics of the enzymatic reactions. 
Using the TLC assay, GOS synthesis from Whey Permeate was confirmed through 
comparison with commercially available GOS preparation Vivinal GOS® (Figure 
3.4).  The effect of enzyme concentration on the maximum GOS yield was also 
observed in these TLC studies (Figure 3.5). This has been previously reported by 
other authors (Čurda et al., 2006; Chockchaisawasdee et al., 2005).  
The TLC method could have been improved by increasing the length of the 
TLC plate or by running the TLC plate twice. However, this would have doubled the 
analysis time, reducing the sample throughput. It is possible that this method may be 
used quantitatively in the future if conditions for separation of components can be 
improved. The method does accurately measure release of monosaccharides and 
might be useful for kinetic studies of the GOS synthesis reaction. Further attempts at 
optimising this assay method were abandoned in favour of a HPLC-based assay. 
 
4.2 Analysis of GOS synthesis by HPLC  
A HPLC solvent system was devised, that separated the components of the 
GOS synthesis reaction and allowed a more precise (Figure 3.9) and accurate (Figure 
3.10) quantitation of GOS components. Despite many attempts, a baseline separation 
of glucose, galactose, lactose and GOS was not achieved. This was the best separation 
obtained considering the time and the resources available. However, separation 
between the components was sufficient to allow their accurate quantitation during 
GOS synthesis. A comparison between data derived by TLC analysis and data 
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obtained by HPLC analysis showed that the former greatly overestimated the level of 
GOS and galactose production and underestimated the lactose concentration.  
Difficulties in accuracy of quantitation of carbohydrates in complex mixtures 
may account for some of the variation in GOS yield reported in the literature. The 
precision of yield data for GOS synthesis in the literature is difficult to assess since 
few reports show chromatograms of GOS synthesis mixtures and many do not give 
estimates of errors associated with GOS measurement which are presented in the form 
of error bars in only a few reports (Martínez-Villaluenga et al., 2008; Li et al., 2008). 
In our hands it was clear that TLC-based methods can greatly overestimate GOS 
synthesis yield compared to the HPLC method. 
The differences between the two analytical methods were highlighted by 
attempts to model the reaction progress curves. High levels of error in parameters 
were associated with TLC derived data. 
A study of enzymatic assays with different concentrations of Maxilact® β-
galactosidase (0.1, 0.4, 0.8, 1.2, 1.6 and 2%) and Whey Permeate (200 and 350 g/l) 
was carried out. The results showed the clear influence of initial enzyme 
concentration on GOS yield as well as its speed of synthesis and degradation, as 
previously observed by other authors (Čurda et al., 2006; Chockchaisawasdee et al., 
2005). High enzyme concentrations led to rapid GOS synthesis but also to its rapid 
degradation. Initial substrate concentration influenced GOS formation, consistent with 
previous studies (Goulas et al., 2007; Maugard et al., 2003). Higher initial lactose 
concentrations increased the transglycosylation reaction to favour GOS synthesis 
rather then monosaccharides formation. A yield analysis of GOS synthesis reactions 
led us to obtain an optimum GOS yield of 24% using 0.8% of Maxilact and 350 g/l, 
Whey Permeate (Figure 3.15).  
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4.3 Effect of solvent addition on GOS synthesis  
A study of solvent addition on the enzymatic synthesis of GOS was carried 
out. Low solvent concentrations (10%) were tested in order not to inhibit the β-
galactosidase action. The solvents used were acetone, acetonitrile, ethanol, diethyl 
ether and dioxane. These solvents were chosen after a review of previous work in the 
literature on the effect of solvents on β-galactosidase activity (Yoon et al., 2005; 
Giacomini et al., 2002). In comparison to the assay without solvent addition, it was 
observed that some solvents inhibited β-galactosidase activity (dioxane and 
acetonitrile) while other solvents (acetone, diethyl ether and ethanol) gave similar 
profiles to the control (Figure 3.31). Further work on the effects of solvents on the 
transglycosylation reaction, especially of ethers would be of considerable interest. The 
reduction of water activity by diethyl ether (Table 3.6) and the low polarity of those 
compounds may avoid β-galactosidase inactivation (Yoon et al., 2005). 
 
4.4 Comparison of different sources of β-galactosidase 
A significant effort, as judged by the number of literature reports, has gone 
into finding enzymes that will enhance the yield of GOS. It is generally believed that 
certain enzymes (from yeast) are better than others (from bacteria) at catalysing GOS 
synthesis (Rustom et al., 1998).  
In selecting the best enzyme for GOS synthesis the studies in the literature are 
confusing (Table 1.5-1.10). Thus, it is almost impossible to compare studies with 
different enzymes since they are carried out under different conditions of pH, 
substrate concentration, enzyme activity, temperature and ionic strength, all of which 
might be expected to influence GOS production. To address this issue we have 
compared GOS synthesis for two enzymes under identical conditions of pH, ionic 
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strength, and temperature and substrate concentration. Crucially, the two enzymes 
were compared at the same level of catalytic activity. This was achieved by using a 
quantity of each enzyme that gave the same initial rate of lactose depletion using the 
HPLC assay method. The enzymes were selected such that they had a significant 
difference in primary sequence. Despite β-galactosidases having different origins and 
properties, the active site of β-galactosidases are highly conserved. It has been shown 
that the key residues of the catalytic site for microbial β-galactosidases are a pair of 
glutamic acid residues (Table 1.11, Zhou et al., 2003). BLAST analysis revealed the 
two enzymes used in this study, one prokaryotic, the other eukaryotic, were ca. 40% 
identical (Figure 3.39). 
Under the conditions used here we found that when these enzymes were 
compared directly, there was no significant difference between them in terms of GOS 
synthesis profile (Figure 3.39). This study is preliminary and should be extended to a 
greater number of enzymes. Nonetheless, it raises the possibility that the differences 
between enzymes in GOS synthesis profiles may be related more to factors such as 
assay conditions and the specific activity of the enzyme preparations rather than 
inherent differences in selectivity. 
GOS synthesis is clearly, from Figure 3.23, a competitive process with 
hydrolysis. Thus, the enzyme-galactosyl complex caused by lactose binding to β-
galactosidases may either react with water or an alternative acceptor. It is difficult to 
envisage how an enzyme might be selected that favoured the alternative acceptor. 
Water is a less bulky and more mobile species than dissolved carbohydrates. The 
active site is necessarily open in order to accommodate the bulk of lactose. Therefore, 
it seems likely that competition between these reaction pathways is mainly influenced 
by thermodynamic factors such as lactose concentration and water activity. Many 
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enzymes may catalyse this reaction with equal efficiency. Further analytical 
developments in addition to further enzymatic studies are needed to establish this 
point but preliminary evidence supports this conclusion.  
 
4.5 Optimisation of GOS yield 
From the arguments above, it is clear that manipulation of water activity, 
lactose concentration and reaction products may enhance GOS synthesis. Many 
studies have shown that elevated lactose concentrations increase GOS yield (Goulas et 
al., 2007). Unfortunately, the attainable lactose concentrations are limited by its low 
water solubility. Furthermore, increased viscosity of the reaction medium at high 
lactose levels may slow the reaction kinetics, delaying the reaction time at which 
maximum GOS is achieved. Relatively few studies have attempted to reduce water 
activity as a method to enhance GOS synthesis. The effect of agents such as solvents 
on GOS synthesis has also been little explored and was mostly focused on β-
galactosidase inactivation (Yoon et al., 2005). Another strategy: the removal of 
products by separation techniques has been attempted, but methods for separation are 
complex and expensive and are not suitable for large scale industrial application. 
We attempted to isolate a high GOS fraction for commercial application by 
selective crystallization of lactose. This sugar is known to crystallise readily in a 
number of food systems. This work did not yield crystals due to the formation of an 
high viscosity syrup when water was evaporated from GOS synthesis reaction 
mixtures. This syrup seemed to inhibit crystal formation. This work was preliminary 
and did not consider a wide variety of crystallisation conditions. Further efforts in this 
area might prove rewarding. 
 
______________________________________________________Chapter 4: Discussion 
 134
4.6 Mathematical modelling of GOS synthesis reaction 
4.6.1 Full model applied on TLC data 
The GOS synthesis reaction was modelled based on a mechanism (equations 
3.1-3.4) described by Kim et al. (2004). The GOS synthesis reaction model had been 
previously modelled in the literature using the King-Altman transformation (Boon et 
al., 1999 and 2000; Neri et al., 2009). However, in the present work, the King-Altman 
transformation could not be used since an effect of enzyme concentration on GOS 
yield was observed (Figure 3.5). Therefore, the model of Kim et al. (2004) was 
chosen to fit the experimental data, since it considered enzyme concentration as part 
of the mechanism and had the most complete set of hypotheses. The model fitted the 
experimental data well (Figure 3.7), but precision problems arising from high standard 
deviations in the estimates of parameters and kinetic parameters with large correlation 
led to the search for a reduced model. Generally, a correlation higher than 0.95 
between kinetic parameters will generate doubts about their estimation and associated 
errors (Donaldson et al., 1987).    
 
4.6.2 Reduced model applied to HPLC data 
The experimental data obtained with the HPLC assay were initially fitted 
using the aforementioned mathematical model (equation 3.15-3.17), based on that of 
Kim et al. (2004). Some GOS synthesis models previously proposed in the literature, 
i.e. Iwasaki et al. (1996), Zhou et al. (2003), used a high number of parameters in the 
model - up to nine parameters in some cases. In the present work, a simplified 
mathematical model was proposed, using a smaller numbers of reaction steps and with 
five parameters, to explain the transglycosylation reaction. This reduced reaction 
mechanism avoided an ill-conditioned model. The reduced model was based on some 
______________________________________________________Chapter 4: Discussion 
 135
considerations that emerged on the basis of a literature review of GOS reaction 
modelling (Boon et al., 1999 and 2000; Zhou et al., 2003). The simplifications we 
employed considered a rapid interaction between lactose and the active site of the 
enzyme, which was considered as an irreversible step. Allolactose formation, as an 
intermediary step of GOS formation (Jobe et al., 1972), was assumed to be of 
negligible influence. The reduced model obtained, and its simplifications, was similar 
to other models in literature (Boon et al., 1999, 2000; Neri et al., 2009). 
The reduced model was shown to have the same precision as the full model 
and also a considerably lower degree of correlation between parameters (Table 3.3). 
The experimental data obtained from GOS synthesis with different Maxilact and 
Whey Permeate concentrations was fitted both as single experiments and as a global 
set of data.  
The individual fitting of the enzymatic assays with the reduced model (Figure 
3.17-3.22) gave a good prediction of the reaction mixture changes during GOS 
synthesis by β-galactosidase. The kinetic parameters obtained through the data 
modelling as single experiments were always significant (Table 3.4). From a study of 
the individual fits, excluding some outliers, there might be a unique set of parameters 
that would fit all the experimental data obtained. 
To estimate general kinetic parameters for the whole transglycosylation 
reactions studied, a global fitting of the experimental data available was carried out. 
Data screening was applied by considering the ratio between the residual glucose and 
galactose present in the synthesis mixture, as previously shown by other authors 
(Boon et al., 1999). This system allowed the elimination of experimental data with an 
error greater than 10%, in order to yield a more homogeneous set of data.  
______________________________________________________Chapter 4: Discussion 
 136
The global fitting was firstly applied by separating the data sets on the basis of 
initial WP concentration, and then by considering all the data together. The estimation 
of the assays with 200 g/l Whey Permeate did not converge to a meaningful result. 
The global fitting of all the data showed a good fit for both of the initial WP 
concentrations used, especially for the synthesised GOS (Figures 3.27-3.30). In the 
fitting of all the data, two kinetic parameters gave a high standard error (Table 3.5). In 
order to obtain more information about these parameters further experiments are 
needed using changing substrate/enzyme concentrations levels. The set of fitting 
kinetic parameters obtained with 350 g/l WP is not significantly different to the 200 
and 350 g/l in the global model, with the exception of ln(k1). This result might 
indicate the necessity to analyse the data using a model that could consider differences 
between assays with 200 g/l WP and 350 g/l in ln(k1). 
 
4.6.3 Reduced model applied to experiments in the presence of solvents 
The reduced model GOS synthesis mechanism (equation 3.15-3.17) was used 
to fit the GOS synthesis profiles in the presence of solvents. The ratio between 
ln(k3)/ln(kr3) (Figure 3.35) indicated that the relative importance of the hydrolysis of 
E:Gal complex (a GOS precursor) had been reduced in the presence of dioxane and 
diethyl ether. The ratio between ln(k5)/ln(kr5) (Figure 3.38) for the experiment with 
dioxane was found to be significantly smaller than for the other assays carried out. 
This may explain the lower level of GOS production in the presence of dioxane 
(Figure 3.31). The ratio between ln(k5)/ln(kr5) (Figure 3.38) showed that reactions in 
the presence of acetone, ethanol and diethyl ether are not significantly different from 
the control (Figure 3.31). Considering the predicted kinetic parameters for hydrolysis 
of the E:Gal complex (Figure 3.35) versus GOS formation (Figure 3.38), it is clear 
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that GOS formation is enhanced in organic solvents such as acetone and diethyl ether. 
On the basis of these results, future work at increased solvent concentrations may be 
of interest. The effect of low polarity solvents on the transglycosylation reaction may 
also be interesting to explore (Yoon et al., 2005).   
 
4.6.4 Application of reduced model to comparison of β-galactosidases  
The fitting of the experimental data for both β-galactosidases using the 
reduced model (equations 3.15-3.17) showed no significant difference between them 
for kinetic parameters of the GOS synthesis reaction. A fundamental point to note is 
that the β-galactosidases have been employed under identical conditions. If two 
enzymes are compared at different pH/temperature, it is not possible to deduce 
whether any improvement in the GOS yield may be ascribed to the enzyme source or 
to the pH/temperature or other differences in assay conditions. 
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5 Conclusions 
The present work showed that GOS synthesis from β-galactosidase activity on 
Whey Permeate is possible. Enzyme and substrate concentration together with solvent 
were factors which were shown to significantly affect the level of GOS synthesised, 
while the enzyme source did not. GOS reaction kinetics could be described by a 
simple reaction mechanism, which allowed the prediction of GOS synthesis kinetics. 
This may have future industrial applications.   
TLC analysis proved to be an adequate screening technique, but when 
quantitative methods were required, HPLC with RI was found to be the more 
appropriate method for monitoring GOS synthesis. 
A simplified reaction mechanism model, that would take into consideration the 
enzyme concentration, was proposed and used to fit GOS synthesis experimental data. 
The estimated parameters from experiments were successfully used to compare and 
interpret changes in the reaction profile. Changes in model parameters due to the use 
of different lactose or enzyme concentrations, the use of solvents in the reaction 
media or due to the employment of different enzyme sources were investigated.  
A maximum GOS yield of 24% was achieved, which is comparable with the 
present literature results. Although higher yields of GOS have been reported in the 
past, they do not seem to be reproducible by most of the studies on 
galactooligosaccharides synthesis from different β-galactosidases sources (Tables 1.5-
1.10). Thus, recent reports in the literature do not claim higher than 25% GOS 
production despite the wide variety of enzymes and reaction conditions used. It is 
possible that this is due to the fact that this reaction is governed by thermodynamic 
factors that are not greatly influenced by reaction conditions.  
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Increasing enzyme concentration resulted in faster synthesis and degradation 
of GOS for a given WP concentration. Increasing WP concentration increased the 
level of GOS synthesised and increased the time taken to reach maximum GOS 
concentration. 
Using 10% acetone, diethyl ether and ethanol influenced the profile of the 
GOS reaction progress, apparently shifting the kinetics towards GOS production and 
away from hydrolysis. 
Comparison of two β-galactosidases under identical conditions showed that 
they had the same GOS synthesis profile when initial rates were normalised. From 
this work it is clearly necessary to have a common protocol to compare β-
galactosidases from different sources. This would ameliorate the difficulties in 
obtaining any meaningful benchmark from previous results in the literature. 
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6 Further work proposed 
On the basis of the results obtained in this work, it would be interesting to 
carry out further research to investigate the effect of higher WP concentration on GOS 
maximum yield and to study the effect of viscosity of the reaction medium on the 
enzymatic reaction. Particularly, the effect of 0.4 and 0.8% Maxilact on 
concentrations of 450 and 550 g/l Whey Permeate should be tested.  
Considering the results with solvent addition, work should be carried out to 
examine increasing the level of the solvent to 20 and 30%, for example. The solvents 
most interesting for further study are acetone and ethanol, as these were shown to 
positively influence the kinetic parameters of the GOS synthesis reaction. 
Furthermore, it may be interesting to study solvent addition to concentrated Whey 
Permeate solutions. This would provide the possibility to combine the favourable 
effect of reduced water activity due to the solvent with high substrate concentration, 
which might improve GOS final yield. 
A standard GOS assay for β-galactosidase should be adopted in order to have 
a comparable set of conditions to benchmark different literature studies present on the 
subject. 
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